{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T15:26:38Z","timestamp":1779377198065,"version":"3.53.1"},"reference-count":223,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s12035-026-05803-1","type":"journal-article","created":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T06:19:01Z","timestamp":1773901141000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Therapeutic Potential of Somatostatin and Its Analogues in Alzheimer\u2019s Disease: From Molecular Mechanisms to Preclinical Studies"],"prefix":"10.1007","volume":"63","author":[{"given":"Kai","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi-Yu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-Ting","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Run","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Run-Hao","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-hua","family":"Bing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,19]]},"reference":[{"issue":"5","key":"5803_CR1","doi-asserted-by":"publisher","first-page":"3708","DOI":"10.1002\/alz.13809","volume":"20","author":"Alzheimer's disease facts and figures","year":"2024","unstructured":"Alzheimer\u2019s disease facts and figures (2024) Alzheimers Dement 20(5):3708\u20133821. https:\/\/doi.org\/10.1002\/alz.13809","journal-title":"Alzheimers Dement"},{"issue":"1","key":"5803_CR2","doi-asserted-by":"publisher","first-page":"35","DOI":"10.54254\/2753-8818\/2024.la18037","volume":"65","author":"H Ni","year":"2024","unstructured":"Ni H (2024) Review of Alzheimer\u2019s disease and treatments. Theoretical and Natural Science 65(1):35\u201340. https:\/\/doi.org\/10.54254\/2753-8818\/2024.la18037","journal-title":"Theoretical and Natural Science"},{"issue":"35","key":"5803_CR3","doi-asserted-by":"publisher","first-page":"21957","DOI":"10.1007\/s00521-024-10399-5","volume":"36","author":"N Kishore","year":"2024","unstructured":"Kishore N, Goel N (2024) A review of machine learning techniques for diagnosing Alzheimer\u2019s disease using imaging modalities. Neural Comput Appl 36(35):21957\u201321984. https:\/\/doi.org\/10.1007\/s00521-024-10399-5","journal-title":"Neural Comput Appl"},{"issue":"3","key":"5803_CR4","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1007\/s00739-024-00998-1","volume":"27","author":"P Dal-Bianco","year":"2024","unstructured":"Dal-Bianco P (2024) Kausale Alzheimertherapie. psychopraxis neuropraxis 27(3):124\u2013128. https:\/\/doi.org\/10.1007\/s00739-024-00998-1","journal-title":"psychopraxis neuropraxis"},{"key":"5803_CR5","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2025-105955","author":"M Rahman","year":"2025","unstructured":"Rahman M, Tabassum A, Sultana S et al (2025) Epidemiology and risk factors of Alzheimer\u2019s disease and related dementias in South and Southeast Asia: a systematic review and meta-analysis protocol. BMJ Open. https:\/\/doi.org\/10.1136\/bmjopen-2025-105955","journal-title":"BMJ Open"},{"issue":"3","key":"5803_CR6","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1002\/agm2.12260","volume":"6","author":"M Ramadan","year":"2023","unstructured":"Ramadan M (2023) Temporal patterns of the burden of Alzheimer\u2019s disease and their association with <scp>Sociodemographic<\/scp> index in countries with varying rates of aging 1990\u20132019. AGING MEDICINE 6(3):281\u2013289. https:\/\/doi.org\/10.1002\/agm2.12260","journal-title":"AGING MEDICINE"},{"key":"5803_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2021.101321","volume":"68","author":"T Zhang","year":"2021","unstructured":"Zhang T, Ma S, Lv J et al (2021) The emerging role of exosomes in Alzheimer\u2019s disease. Ageing Res Rev 68:101321. https:\/\/doi.org\/10.1016\/j.arr.2021.101321","journal-title":"Ageing Res Rev"},{"issue":"7","key":"5803_CR8","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1007\/s00108-013-3289-5","volume":"54","author":"D Kopf","year":"2013","unstructured":"Kopf D, R\u00f6sler A (2013) Demenz. Internist (Berl) 54(7):827\u2013843. https:\/\/doi.org\/10.1007\/s00108-013-3289-5","journal-title":"Internist (Berl)"},{"key":"5803_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.rechem.2024.101463","volume":"7","author":"A Puri","year":"2024","unstructured":"Puri A, Mohite P, Khan S, Singh S (2024) Breaking the barriers in management of Alzheimer\u2019s disease through cationic nanoformulation: a review. Results Chem 7:101463. https:\/\/doi.org\/10.1016\/j.rechem.2024.101463","journal-title":"Results Chem"},{"key":"5803_CR10","doi-asserted-by":"publisher","unstructured":"J. W. Yamin Zhang, Jin Yuan, Ruipeng Wu et al. The Role of Somatostatin in Alzheimer's Disease: Modulation of NLRP3-Mediated Microglial Pyroptosis via the MDM2\/DPP4\/Sirt1 axis. Journal of Biological Regulators and Homeostatic Agents. 2024; 38(3):https:\/\/doi.org\/10.23812\/j.biol.regul.homeost.agents.20243803.171","DOI":"10.23812\/j.biol.regul.homeost.agents.20243803.171"},{"key":"5803_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2024.102255","volume":"96","author":"PS Rakshe","year":"2024","unstructured":"Rakshe PS, Dutta BJ, Chib S et al (2024) Unveiling the interplay of AMPK\/SIRT1\/PGC-1\u03b1 axis in brain health: promising targets against aging and NDDs. Ageing Res Rev 96:102255. https:\/\/doi.org\/10.1016\/j.arr.2024.102255","journal-title":"Ageing Res Rev"},{"issue":"6","key":"5803_CR12","doi-asserted-by":"publisher","first-page":"3479","DOI":"10.1007\/s10787-025-01755-5","volume":"33","author":"ES Abdel-lah","year":"2025","unstructured":"Abdel-lah ES, Sherkawy HS, Mohamed WH et al (2025) Empagliflozin and memantine combination ameliorates cognitive impairment in scopolamine + heavy metal mixture-induced Alzheimer\u2019s disease in rats: role of AMPK\/mTOR, BDNF, BACE-1, neuroinflammation, and oxidative stress. Inflammopharmacology 33(6):3479\u20133498. https:\/\/doi.org\/10.1007\/s10787-025-01755-5","journal-title":"Inflammopharmacology"},{"key":"5803_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.116373","volume":"173","author":"Z Zhao","year":"2024","unstructured":"Zhao Z, Yan J, Huang L, Yang X (2024) Phytochemicals targeting Alzheimer\u2019s disease via the AMP-activated protein kinase pathway, effects, and mechanisms of action. Biomed Pharmacother 173:116373. https:\/\/doi.org\/10.1016\/j.biopha.2024.116373","journal-title":"Biomed Pharmacother"},{"key":"5803_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.mtbio.2023.100701","volume":"21","author":"SS Naser","year":"2023","unstructured":"Naser SS, Singh D, Preetam S et al (2023) Posterity of nanoscience as lipid nanosystems for Alzheimer\u2019s disease regression. Mater Today Bio 21:100701. https:\/\/doi.org\/10.1016\/j.mtbio.2023.100701","journal-title":"Mater Today Bio"},{"issue":"3","key":"5803_CR15","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1038\/s12276-021-00580-4","volume":"53","author":"YH Song","year":"2021","unstructured":"Song YH, Yoon J, Lee SH (2021) The role of neuropeptide somatostatin in the brain and its application in treating neurological disorders. Exp Mol Med 53(3):328\u2013338. https:\/\/doi.org\/10.1038\/s12276-021-00580-4","journal-title":"Exp Mol Med"},{"key":"5803_CR16","doi-asserted-by":"publisher","DOI":"10.3389\/fncir.2024.1436915","author":"A Agmon","year":"2024","unstructured":"Agmon A, Barth AL (2024) A brief history of somatostatin interneuron taxonomy or: how many somatostatin subtypes are there, really? Front Neural Circuits. https:\/\/doi.org\/10.3389\/fncir.2024.1436915","journal-title":"Front Neural Circuits"},{"issue":"1-2","key":"5803_CR17","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.mce.2008.02.029","volume":"286","author":"H Tostivint","year":"2008","unstructured":"Tostivint H, Lihrmann I, Vaudry H (2008) New insight into the molecular evolution of the somatostatin family. Mol Cell Endocrinol 286(1\u20132):5\u201317. https:\/\/doi.org\/10.1016\/j.mce.2008.02.029","journal-title":"Mol Cell Endocrinol"},{"key":"5803_CR18","doi-asserted-by":"publisher","DOI":"10.32388\/goy6dk","author":"VN Almeida","year":"2023","unstructured":"Almeida VN (2023) Somatostatin and the pathophysiology of Alzheimer\u2019s disease. Qeios. https:\/\/doi.org\/10.32388\/goy6dk","journal-title":"Qeios"},{"key":"5803_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s42003-022-04268-x","author":"M Algamal","year":"2022","unstructured":"Algamal M, Russ AN, Miller MR et al (2022) Reduced excitatory neuron activity and interneuron-type-specific deficits in a mouse model of Alzheimer\u2019s disease. Commun Biol. https:\/\/doi.org\/10.1038\/s42003-022-04268-x","journal-title":"Commun Biol"},{"issue":"3","key":"5803_CR20","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.1038\/s41380-021-01368-8","volume":"27","author":"N Watamura","year":"2022","unstructured":"Watamura N, Kakiya N, Nilsson P et al (2022) Somatostatin-evoked A\u03b2 catabolism in the brain: Mechanistic involvement of \u03b1-endosulfine-K(ATP) channel pathway. Mol Psychiatry 27(3):1816\u20131828. https:\/\/doi.org\/10.1038\/s41380-021-01368-8","journal-title":"Mol Psychiatry"},{"issue":"3","key":"5803_CR21","doi-asserted-by":"publisher","first-page":"3","DOI":"10.54059\/2021.4(3)crjpas_206","volume":"4","author":"P Sadhu","year":"2021","unstructured":"Sadhu P, Sen S, Vanlalhriatpuii C (2021) Comprehensive review on Alzheimer\u2019s disease: pathophysiology and its treatment. Current Research Journal of Pharmaceutical and Allied Sciences 4(3):3\u201312. https:\/\/doi.org\/10.54059\/2021.4(3)crjpas_206","journal-title":"Current Research Journal of Pharmaceutical and Allied Sciences"},{"key":"5803_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2024.102199","author":"N Liu","year":"2024","unstructured":"Liu N, Liang X, Chen Y, Xie L (2024) Recent trends in treatment strategies for Alzheimer\u2019s disease and the challenges: a topical advancement. Ageing Res Rev. https:\/\/doi.org\/10.1016\/j.arr.2024.102199","journal-title":"Ageing Res Rev"},{"key":"5803_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2025.118325","author":"NG Metzendorf","year":"2025","unstructured":"Metzendorf NG, Godec A, Petrovic A et al (2025) Somatostatin therapy, neprilysin activation, and amyloid beta reduction: a novel approach for Alzheimer\u2019s treatment. Biomed Pharmacother. https:\/\/doi.org\/10.1016\/j.biopha.2025.118325","journal-title":"Biomed Pharmacother"},{"key":"5803_CR24","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.bbi.2023.11.004","volume":"115","author":"I Boyton","year":"2024","unstructured":"Boyton I, Valenzuela SM, Collins-Praino LE (2024) Neuronanomedicine for Alzheimer\u2019s and Parkinson\u2019s disease: current progress and a guide to improve clinical translation. Brain Behav Immun 115:631\u2013651. https:\/\/doi.org\/10.1016\/j.bbi.2023.11.004","journal-title":"Brain Behav Immun"},{"key":"5803_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2025.107012","volume":"213","author":"KS Chen","year":"2025","unstructured":"Chen KS, Noureldein MH, Rigan DM et al (2025) Interneuron transcriptomics reveals pathologic markers of Alzheimer\u2019s disease progression. Neurobiol Dis 213:107012. https:\/\/doi.org\/10.1016\/j.nbd.2025.107012","journal-title":"Neurobiol Dis"},{"issue":"7","key":"5803_CR26","doi-asserted-by":"publisher","first-page":"4677","DOI":"10.1002\/alz.13900","volume":"20","author":"J Guptarak","year":"2024","unstructured":"Guptarak J, Scaduto P, Tumurbaatar B et al (2024) Cognitive integrity in Non-Demented Individuals with Alzheimer\u2019s Neuropathology is associated with preservation and remodeling of dendritic spines. Alzheimers Dement 20(7):4677\u20134691. https:\/\/doi.org\/10.1002\/alz.13900","journal-title":"Alzheimers Dement"},{"key":"5803_CR27","doi-asserted-by":"publisher","unstructured":"R. Lattmann-Grefe, N. Vockert, J. Machts et al. Dysfunction of the episodic memory network in the Alzheimer\u2019s disease cascade. bioRxiv. 2024; https:\/\/doi.org\/10.1101\/2024.10.25.620237","DOI":"10.1101\/2024.10.25.620237"},{"key":"5803_CR28","doi-asserted-by":"publisher","unstructured":"u. undefined, R. R. Rodr\u00edguez, L. E. R. Estrada et al. Molecular Mechanisms Associated with Neurodegeneration in Alzheimer's disease. International Journal of Medical Science and Clinical Research Studies. 2024; 4(2):https:\/\/doi.org\/10.47191\/ijmscrs\/v4-i02-17","DOI":"10.47191\/ijmscrs\/v4-i02-17"},{"issue":"8","key":"5803_CR29","doi-asserted-by":"publisher","first-page":"3905","DOI":"10.3390\/ijms26083905","volume":"26","author":"H Xing","year":"2025","unstructured":"Xing H, Yue S, Qin R et al (2025) Recent Advances in Drug Development for Alzheimer\u2019s Disease: A Comprehensive Review. Int J Mol Sci 26(8):3905. https:\/\/doi.org\/10.3390\/ijms26083905","journal-title":"Int J Mol Sci"},{"key":"5803_CR30","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2022.903175","author":"ME Consens","year":"2022","unstructured":"Consens ME, Chen Y, Menon V et al (2022) Bulk and single-nucleus transcriptomics highlight intra-telencephalic and somatostatin neurons in Alzheimer\u2019s disease. Front Mol Neurosci. https:\/\/doi.org\/10.3389\/fnmol.2022.903175","journal-title":"Front Mol Neurosci"},{"key":"5803_CR31","doi-asserted-by":"publisher","unstructured":"H. M. Al-kuraishy, M. S. Jabir, A. K. Albuhadily et al. Role of ketogenic diet in neurodegenerative diseases focusing on Alzheimer diseases: The guardian angle. Ageing Research Reviews. 2024; 95102233. https:\/\/doi.org\/10.1016\/j.arr.2024.102233","DOI":"10.1016\/j.arr.2024.102233"},{"key":"5803_CR32","doi-asserted-by":"publisher","unstructured":"Y. Ma, X. Wang, M. Gao et al. Microglia-Neuron Interactions in Alzheimer\u2019s Disease. Current Neuropharmacology. 2025; 23https:\/\/doi.org\/10.2174\/011570159x379539250807114252","DOI":"10.2174\/011570159x379539250807114252"},{"issue":"1","key":"5803_CR33","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.ijrobp.2023.11.044","volume":"119","author":"D Kaul","year":"2024","unstructured":"Kaul D, Ehret F, Roohani S et al (2024) Radiation Therapy in Alzheimer\u2019s Disease: A Systematic Review. International Journal of Radiation Oncology Biology Physics 119(1):23\u201341. https:\/\/doi.org\/10.1016\/j.ijrobp.2023.11.044","journal-title":"International Journal of Radiation Oncology Biology Physics"},{"issue":"12","key":"5803_CR34","doi-asserted-by":"publisher","first-page":"5026","DOI":"10.1007\/s12035-020-02073-3","volume":"57","author":"S Liu","year":"2020","unstructured":"Liu S, Gao J, Zhu M, Liu K, Zhang H-L (2020) Gut microbiota and dysbiosis in Alzheimer\u2019s disease: implications for pathogenesis and treatment. Mol Neurobiol 57(12):5026\u20135043. https:\/\/doi.org\/10.1007\/s12035-020-02073-3","journal-title":"Mol Neurobiol"},{"key":"5803_CR35","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.neuroscience.2025.03.033","volume":"573","author":"J Chen","year":"2025","unstructured":"Chen J, Xu S, Wang L et al (2025) Refining the interactions between microglia and astrocytes in Alzheimer\u2019s disease pathology. Neuroscience 573:183\u2013197. https:\/\/doi.org\/10.1016\/j.neuroscience.2025.03.033","journal-title":"Neuroscience"},{"key":"5803_CR36","doi-asserted-by":"publisher","unstructured":"A. F. T. Arnsten, K. Del Tredici, N. R. Barth\u00e9lemy et al. An integrated view of the relationships between amyloid, tau, and inflammatory pathophysiology in Alzheimer's disease. Alzheimer's & Dementia. 2025;21(8):https:\/\/doi.org\/10.1002\/alz.70404","DOI":"10.1002\/alz.70404"},{"key":"5803_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2023.102084","author":"HM Al-kuraishy","year":"2023","unstructured":"Al-kuraishy HM, Jabir MS, Albuhadily AK et al (2023) The link between metabolic syndrome and Alzheimer disease: a mutual relationship and long rigorous investigation. Ageing Res Rev. https:\/\/doi.org\/10.1016\/j.arr.2023.102084","journal-title":"Ageing Res Rev"},{"issue":"5","key":"5803_CR38","doi-asserted-by":"publisher","DOI":"10.3390\/antiox13050606","volume":"13","author":"MI Prasanth","year":"2024","unstructured":"Prasanth MI, Sivamaruthi BS, Cheong CSY et al (2024) Role of epigenetic modulation in neurodegenerative diseases: implications of phytochemical interventions. Antioxidants 13(5):606. https:\/\/doi.org\/10.3390\/antiox13050606","journal-title":"Antioxidants"},{"issue":"1","key":"5803_CR39","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s40883-024-00340-6","volume":"11","author":"NS Kiran","year":"2024","unstructured":"Kiran NS, Vaishnavi G, Singh S et al (2024) Biomaterials Comprising Implantable and Dermal Drug Delivery Targeting Brain in Management of Alzheimer\u2019s Disease: A Review. Regenerative Engineering and Translational Medicine 11(1):15\u201338. https:\/\/doi.org\/10.1007\/s40883-024-00340-6","journal-title":"Regenerative Engineering and Translational Medicine"},{"key":"5803_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2025.118325","volume":"189","author":"NG Metzendorf","year":"2025","unstructured":"Metzendorf NG, Godec A, Petrovic A et al (2025) Somatostatin therapy, neprilysin activation, and amyloid beta reduction: a novel approach for Alzheimer\u2019s treatment. Biomed Pharmacother 189:118325. https:\/\/doi.org\/10.1016\/j.biopha.2025.118325","journal-title":"Biomed Pharmacother"},{"issue":"3","key":"5803_CR41","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.nrleng.2025.03.008","volume":"40","author":"R Mondal","year":"2025","unstructured":"Mondal R, Deb S, Shome G et al (2025) Molecular dynamics of amyloid-\u03b2 transport in Alzheimer\u2019s disease: Exploring therapeutic plasma exchange with albumin replacement \u2013 Current insights and future perspectives. Neurolog\u00eda (English Edition) 40(3):306\u2013328. https:\/\/doi.org\/10.1016\/j.nrleng.2025.03.008","journal-title":"Neurolog\u00eda (English Edition)"},{"issue":"1","key":"5803_CR42","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1007\/s12035-018-1045-5","volume":"56","author":"S Paik","year":"2018","unstructured":"Paik S, Somvanshi RK, Kumar U (2018) Somatostatin maintains permeability and integrity of blood-brain barrier in \u03b2-amyloid induced toxicity. Mol Neurobiol 56(1):292\u2013306. https:\/\/doi.org\/10.1007\/s12035-018-1045-5","journal-title":"Mol Neurobiol"},{"key":"5803_CR43","doi-asserted-by":"publisher","DOI":"10.1101\/2020.05.11.088153","author":"E Puig","year":"2020","unstructured":"Puig E, Tolchard J, Riera A, Carulla N (2020) Somatostatin, anIn VivoBinder to A\u03b2 Oligomers, Binds to \u03b2PFOA\u03b2(1-42)Tetramer. bioRxiv. https:\/\/doi.org\/10.1101\/2020.05.11.088153","journal-title":"bioRxiv"},{"issue":"20","key":"5803_CR44","doi-asserted-by":"publisher","first-page":"3358","DOI":"10.1021\/acschemneuro.0c00470","volume":"11","author":"E Puig","year":"2020","unstructured":"Puig E, Tolchard J, Riera A, Carulla N (2020) Somatostatin, an In Vivo Binder to A\u03b2 Oligomers, Binds to \u03b2PFOA\u03b2(1\u201342) Tetramers. ACS Chem Neurosci 11(20):3358\u20133365. https:\/\/doi.org\/10.1021\/acschemneuro.0c00470","journal-title":"ACS Chem Neurosci"},{"key":"5803_CR45","doi-asserted-by":"publisher","unstructured":"M. Solarski, D. Williams, M. Mehrabian et al. The human brain somatostatin interactome: SST binds selectively to P-type family ATPases. PLOS ONE. 2019;14(5):https:\/\/doi.org\/10.1371\/journal.pone.0217392","DOI":"10.1371\/journal.pone.0217392"},{"issue":"3","key":"5803_CR46","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.1038\/s41380-021-01368-8","volume":"27","author":"N Watamura","year":"2021","unstructured":"Watamura N, Kakiya N, Nilsson P et al (2021) Somatostatin-evoked A\u03b2 catabolism in the brain: Mechanistic involvement of \u03b1-endosulfine-KATP channel pathway. Mol Psychiatry 27(3):1816\u20131828. https:\/\/doi.org\/10.1038\/s41380-021-01368-8","journal-title":"Mol Psychiatry"},{"issue":"2","key":"5803_CR47","doi-asserted-by":"publisher","first-page":"789","DOI":"10.7150\/thno.50263","volume":"11","author":"F Rofo","year":"2021","unstructured":"Rofo F, Ugur Yilmaz C, Metzendorf N et al (2021) Enhanced neprilysin-mediated degradation of hippocampal A\u03b242 with a somatostatin peptide that enters the brain. Theranostics 11(2):789\u2013804. https:\/\/doi.org\/10.7150\/thno.50263","journal-title":"Theranostics"},{"issue":"13","key":"5803_CR48","doi-asserted-by":"publisher","first-page":"2529","DOI":"10.1021\/acschemneuro.1c00303","volume":"12","author":"F Rofo","year":"2021","unstructured":"Rofo F, Sandbaumh\u00fcter FA, Chourlia A et al (2021) Wide-ranging effects on the brain proteome in a transgenic mouse model of Alzheimer\u2019s disease following treatment with a brain-targeting somatostatin peptide. ACS Chem Neurosci 12(13):2529\u20132541. https:\/\/doi.org\/10.1021\/acschemneuro.1c00303","journal-title":"ACS Chem Neurosci"},{"key":"5803_CR49","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2024.102270","volume":"96","author":"VN Almeida","year":"2024","unstructured":"Almeida VN (2024) Somatostatin and the pathophysiology of Alzheimer\u2019s disease. Ageing Res Rev 96:102270. https:\/\/doi.org\/10.1016\/j.arr.2024.102270","journal-title":"Ageing Res Rev"},{"key":"5803_CR50","doi-asserted-by":"publisher","unstructured":"D. Williams, B. Q. Yan, H. Wang et al. Somatostatin slows A\u03b2 plaque deposition in aged APPNL-F\/NL-F mice by blocking A\u03b2 aggregation. Scientific Reports. 2023; 13(1):https:\/\/doi.org\/10.1038\/s41598-023-29559-z","DOI":"10.1038\/s41598-023-29559-z"},{"issue":"1","key":"5803_CR51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/19336896.2017.1405207","volume":"12","author":"M Solarski","year":"2018","unstructured":"Solarski M, Wang H, Wille H, Schmitt-Ulms G (2018) Somatostatin in Alzheimer\u2019s disease: A new Role for an Old Player. Prion 12(1):1\u20138. https:\/\/doi.org\/10.1080\/19336896.2017.1405207","journal-title":"Prion"},{"key":"5803_CR52","doi-asserted-by":"publisher","unstructured":"D. Williams, B. Q. Yan, H. Wang et al. Somatostatin slows A\u03b2 plaque deposition in aged APPNL-F\/NL-F mice by blocking A\u03b2 aggregation in a neprilysin-independent manner. bioRxiv. 2022; https:\/\/doi.org\/10.1101\/2022.09.26.509540","DOI":"10.1101\/2022.09.26.509540"},{"key":"5803_CR53","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2022.106631","volume":"187","author":"BP Imbimbo","year":"2023","unstructured":"Imbimbo BP, Ippati S, Watling M, Imbimbo C (2023) Role of monomeric amyloid-\u03b2 in cognitive performance in Alzheimer\u2019s disease: insights from clinical trials with secretase inhibitors and monoclonal antibodies. Pharmacol Res 187:106631. https:\/\/doi.org\/10.1016\/j.phrs.2022.106631","journal-title":"Pharmacol Res"},{"key":"5803_CR54","doi-asserted-by":"publisher","DOI":"10.1186\/s13578-023-01127-y","author":"V Rudajev","year":"2023","unstructured":"Rudajev V, Novotny J (2023) Cholesterol-dependent amyloid \u03b2 production: space for multifarious interactions between amyloid precursor protein, secretases, and cholesterol. Cell Biosci. https:\/\/doi.org\/10.1186\/s13578-023-01127-y","journal-title":"Cell Biosci"},{"key":"5803_CR55","doi-asserted-by":"publisher","unstructured":"H. Prasad and R. Rao. Endosomal Acid-Base Homeostasis in Neurodegenerative Diseases. Reviews of Physiology, Biochemistry and Pharmacology. 2020; 195\u2013231. https:\/\/doi.org\/10.1007\/112_2020_25","DOI":"10.1007\/112_2020_25"},{"key":"5803_CR56","doi-asserted-by":"publisher","unstructured":"u. Neha, Z. Wali, u. Pinky et al. GLP-1\/Sigma\/RAGE receptors: An evolving picture of Alzheimer's disease pathology and treatment. Ageing Research Reviews. 2024; 93102134. https:\/\/doi.org\/10.1016\/j.arr.2023.102134","DOI":"10.1016\/j.arr.2023.102134"},{"issue":"9","key":"5803_CR57","doi-asserted-by":"publisher","first-page":"9721","DOI":"10.3390\/cimb46090578","volume":"46","author":"A Periferakis","year":"2024","unstructured":"Periferakis A, Tsigas G, Periferakis A-T et al (2024) Agonists, Antagonists and Receptors of Somatostatin: Pathophysiological and Therapeutical Implications in Neoplasias. Curr Issues Mol Biol 46(9):9721\u20139759. https:\/\/doi.org\/10.3390\/cimb46090578","journal-title":"Curr Issues Mol Biol"},{"issue":"4","key":"5803_CR58","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1016\/j.immuni.2024.03.010","volume":"57","author":"S Castro-Gomez","year":"2024","unstructured":"Castro-Gomez S, Heneka MT (2024) Innate immune activation in neurodegenerative diseases. Immunity 57(4):790\u2013814. https:\/\/doi.org\/10.1016\/j.immuni.2024.03.010","journal-title":"Immunity"},{"key":"5803_CR59","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2427257122","author":"L Tian","year":"2025","unstructured":"Tian L, Long G, Zhu S et al (2025) Nanoimmunomodulation of the A\u03b2-STING feedback machinery in microglia for Alzheimer\u2019s disease treatment. Proc Natl Acad Sci U S A. https:\/\/doi.org\/10.1073\/pnas.2427257122","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"5803_CR60","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1007\/s12031-019-01291-2","volume":"68","author":"S Paik","year":"2019","unstructured":"Paik S, Somvanshi RK, Kumar U (2019) Somatostatin-Mediated Changes in Microtubule-Associated Proteins and Retinoic Acid-Induced Neurite Outgrowth in SH-SY5Y Cells. J Mol Neurosci 68(1):120\u2013134. https:\/\/doi.org\/10.1007\/s12031-019-01291-2","journal-title":"J Mol Neurosci"},{"issue":"7","key":"5803_CR61","doi-asserted-by":"publisher","first-page":"2568","DOI":"10.3390\/ijms21072568","volume":"21","author":"U Kumar","year":"2020","unstructured":"Kumar U, Singh S (2020) Role of Somatostatin in the Regulation of Central and Peripheral Factors of Satiety and Obesity. Int J Mol Sci 21(7):2568. https:\/\/doi.org\/10.3390\/ijms21072568","journal-title":"Int J Mol Sci"},{"issue":"19","key":"5803_CR62","doi-asserted-by":"publisher","first-page":"3708","DOI":"10.1021\/acschemneuro.1c00432","volume":"12","author":"JP Leite","year":"2021","unstructured":"Leite JP, Lete MG, Fowler SB et al (2021) A\u03b231\u201335 Decreases Neprilysin-Mediated Alzheimer\u2019s Amyloid-\u03b2 Peptide Degradation. ACS Chem Neurosci 12(19):3708\u20133718. https:\/\/doi.org\/10.1021\/acschemneuro.1c00432","journal-title":"ACS Chem Neurosci"},{"key":"5803_CR63","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.neuroscience.2024.11.020","volume":"563","author":"P Khandayataray","year":"2024","unstructured":"Khandayataray P, Murthy MK (2024) Dietary interventions in mitigating the impact of environmental pollutants on Alzheimer\u2019s disease \u2013 a review. Neuroscience 563:148\u2013166. https:\/\/doi.org\/10.1016\/j.neuroscience.2024.11.020","journal-title":"Neuroscience"},{"issue":"6","key":"5803_CR64","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1002\/glia.22974","volume":"64","author":"N Yamamoto","year":"2016","unstructured":"Yamamoto N, Fujii Y, Kasahara R et al (2016) Simvastatin and atorvastatin facilitates amyloid \u03b2-protein degradation in extracellular spaces by increasing neprilysin secretion from astrocytes through activation of <scp>MAPK\/E<\/scp>rk1\/2 pathways. Glia 64(6):952\u2013962. https:\/\/doi.org\/10.1002\/glia.22974","journal-title":"Glia"},{"issue":"9","key":"5803_CR65","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1007\/s00702-020-02232-9","volume":"127","author":"KA Jellinger","year":"2020","unstructured":"Jellinger KA (2020) Neuropathological assessment of the Alzheimer spectrum. J Neural Transm 127(9):1229\u20131256. https:\/\/doi.org\/10.1007\/s00702-020-02232-9","journal-title":"J Neural Transm"},{"key":"5803_CR66","doi-asserted-by":"publisher","unstructured":"P. Nilsson, K. S\u00f6rgjerd, N. Kakiya et al. Somatostatin receptor subtypes 1 and 4 redundantly regulate neprilysin, the major amyloid-beta degrading enzyme in brain. bioRxiv. 2020; https:\/\/doi.org\/10.1101\/2020.05.09.085795","DOI":"10.1101\/2020.05.09.085795"},{"key":"5803_CR67","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-021-02117-y","author":"N Davis","year":"2021","unstructured":"Davis N, Mota BC, Stead L et al (2021) Pharmacological ablation of astrocytes reduces A\u03b2 degradation and synaptic connectivity in an ex vivo model of Alzheimer\u2019s disease. J Neuroinflammation. https:\/\/doi.org\/10.1186\/s12974-021-02117-y","journal-title":"J Neuroinflammation"},{"issue":"16","key":"5803_CR68","doi-asserted-by":"publisher","first-page":"3940","DOI":"10.3390\/ijms20163940","volume":"20","author":"F Gatto","year":"2019","unstructured":"Gatto F, Barbieri F, Arvigo M et al (2019) Biological and Biochemical Basis of the Differential Efficacy of First and Second Generation Somatostatin Receptor Ligands in Neuroendocrine Neoplasms. Int J Mol Sci 20(16):3940. https:\/\/doi.org\/10.3390\/ijms20163940","journal-title":"Int J Mol Sci"},{"key":"5803_CR69","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2023.101999","volume":"90","author":"Y Tian","year":"2023","unstructured":"Tian Y, Jing G, Zhang M (2023) Insulin-degrading enzyme: roles and pathways in ameliorating cognitive impairment associated with Alzheimer\u2019s disease and diabetes. Ageing Res Rev 90:101999. https:\/\/doi.org\/10.1016\/j.arr.2023.101999","journal-title":"Ageing Res Rev"},{"key":"5803_CR70","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.neuroscience.2022.06.034","volume":"568","author":"M Yao","year":"2025","unstructured":"Yao M, Rosario ER, Soper JC et al (2025) Androgens regulate tau phosphorylation through phosphatidylinositol 3-kinase\u2013protein kinase B\u2013glycogen synthase kinase 3\u03b2 signaling. Neuroscience 568:503\u2013518. https:\/\/doi.org\/10.1016\/j.neuroscience.2022.06.034","journal-title":"Neuroscience"},{"issue":"1","key":"5803_CR71","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/s41380-022-01792-4","volume":"28","author":"J Nowell","year":"2022","unstructured":"Nowell J, Blunt E, Edison P (2022) Incretin and insulin signaling as novel therapeutic targets for Alzheimer\u2019s and Parkinson\u2019s disease. Mol Psychiatry 28(1):217\u2013229. https:\/\/doi.org\/10.1038\/s41380-022-01792-4","journal-title":"Mol Psychiatry"},{"key":"5803_CR72","doi-asserted-by":"publisher","unstructured":"S. Garc\u00eda-Roman, M. Garz\u00f3n-Ib\u00e1\u00f1ez, J. Bertr\u00e1n-Alamillo et al. Vaccine antibodies against a synthetic epidermal growth factor variant enhance the antitumor effects of inhibitors targeting the MAPK\/ERK and PI3K\/Akt pathways. Translational Oncology. 2024; 40101878. https:\/\/doi.org\/10.1016\/j.tranon.2024.101878","DOI":"10.1016\/j.tranon.2024.101878"},{"issue":"6","key":"5803_CR73","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.1007\/s12640-022-00588-2","volume":"40","author":"E Uzunhisarc\u0131kl\u0131","year":"2022","unstructured":"Uzunhisarc\u0131kl\u0131 E, Yerer MB (2022) Neuroprotective effects of Vapreotide on tau transfection-induced neurodegeneration. Neurotox Res 40(6):1824\u20131837. https:\/\/doi.org\/10.1007\/s12640-022-00588-2","journal-title":"Neurotox Res"},{"issue":"11","key":"5803_CR74","doi-asserted-by":"publisher","first-page":"2670","DOI":"10.1007\/s11064-019-02890-6","volume":"44","author":"K Sandoval","year":"2019","unstructured":"Sandoval K, Umbaugh D, House A et al (2019) Somatostatin Receptor Subtype-4 Regulates mRNA Expression of Amyloid-Beta Degrading Enzymes and Microglia Mediators of Phagocytosis in Brains of 3xTg-AD Mice. Neurochem Res 44(11):2670\u20132680. https:\/\/doi.org\/10.1007\/s11064-019-02890-6","journal-title":"Neurochem Res"},{"key":"5803_CR75","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2024.102270","author":"VN Almeida","year":"2024","unstructured":"Almeida VN (2024) Somatostatin and the pathophysiology of Alzheimer\u2019s disease. Ageing Res Rev. https:\/\/doi.org\/10.1016\/j.arr.2024.102270","journal-title":"Ageing Res Rev"},{"issue":"17","key":"5803_CR76","doi-asserted-by":"publisher","DOI":"10.3390\/molecules25174012","volume":"25","author":"R Eychenne","year":"2020","unstructured":"Eychenne R, Bouvry C, Bourgeois M et al (2020) Overview of radiolabeled somatostatin analogs for cancer imaging and therapy. Molecules 25(17):4012. https:\/\/doi.org\/10.3390\/molecules25174012","journal-title":"Molecules"},{"issue":"5","key":"5803_CR77","doi-asserted-by":"publisher","first-page":"529","DOI":"10.2174\/1389450116666141205163548","volume":"17","author":"L Sun","year":"2016","unstructured":"Sun L, Coy DH (2016) Somatostatin and its analogs. Curr Drug Targets 17(5):529\u2013537. https:\/\/doi.org\/10.2174\/1389450116666141205163548","journal-title":"Curr Drug Targets"},{"key":"5803_CR78","doi-asserted-by":"publisher","unstructured":"P. Melhorn, P. Mazal, L. Wolff et al. From biology to clinical practice: antiproliferative effects of somatostatin analogs in neuroendocrine neoplasms. Therapeutic Advances in Medical Oncology. 2024; 16https:\/\/doi.org\/10.1177\/17588359241240316","DOI":"10.1177\/17588359241240316"},{"issue":"5","key":"5803_CR79","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21051682","volume":"21","author":"M Gomes-Porras","year":"2020","unstructured":"Gomes-Porras M, C\u00e1rdenas-Salas J, \u00c1lvarez-Escol\u00e1 C (2020) Somatostatin analogs in clinical practice: a review. Int J Mol Sci 21(5):1682. https:\/\/doi.org\/10.3390\/ijms21051682","journal-title":"Int J Mol Sci"},{"issue":"2","key":"5803_CR80","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1007\/s12325-020-01600-x","volume":"38","author":"D Cella","year":"2021","unstructured":"Cella D, Evans J, Feuilly M et al (2021) Patient and Healthcare Provider Perspectives of First-Generation Somatostatin Analogs in the Management of Neuroendocrine Tumors and Acromegaly: A Systematic Literature Review. Adv Ther 38(2):969\u2013993. https:\/\/doi.org\/10.1007\/s12325-020-01600-x","journal-title":"Adv Ther"},{"key":"5803_CR81","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2023.106027","author":"B Villasana-Salazar","year":"2023","unstructured":"Villasana-Salazar B, Vezzani A (2023) Neuroinflammation microenvironment sharpens seizure circuit. Neurobiol Dis. https:\/\/doi.org\/10.1016\/j.nbd.2023.106027","journal-title":"Neurobiol Dis"},{"key":"5803_CR82","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2018.00966","author":"S Sinha","year":"2018","unstructured":"Sinha S, Patro N, Patro IK (2018) Maternal Protein Malnutrition: Current and Future Perspectives of Spirulina Supplementation in Neuroprotection. Front Neurosci. https:\/\/doi.org\/10.3389\/fnins.2018.00966","journal-title":"Front Neurosci"},{"key":"5803_CR83","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuint.2024.105738","author":"NIS Mohamed Yusof","year":"2024","unstructured":"Mohamed Yusof NIS, Mohd Fauzi F (2024) Nature\u2019s Toolbox for Alzheimer\u2019s Disease: A Review on the Potential of Natural Products as Alzheimer\u2019s Disease Drugs. Neurochem Int. https:\/\/doi.org\/10.1016\/j.neuint.2024.105738","journal-title":"Neurochem Int"},{"issue":"11","key":"5803_CR84","doi-asserted-by":"publisher","first-page":"e59","DOI":"10.1016\/j.biopsych.2021.03.028","volume":"89","author":"BD Turner","year":"2021","unstructured":"Turner BD (2021) Changing the stars: astrocytes adapt to coordinate action flexibility. Biol Psychiatry 89(11):e59\u2013e60. https:\/\/doi.org\/10.1016\/j.biopsych.2021.03.028","journal-title":"Biol Psychiatry"},{"issue":"11","key":"5803_CR85","doi-asserted-by":"publisher","first-page":"2698","DOI":"10.3390\/ijms20112698","volume":"20","author":"F Cofano","year":"2019","unstructured":"Cofano F, Boido M, Monticelli M et al (2019) Mesenchymal Stem Cells for Spinal Cord Injury: Current Options, Limitations, and Future of Cell Therapy. Int J Mol Sci 20(11):2698. https:\/\/doi.org\/10.3390\/ijms20112698","journal-title":"Int J Mol Sci"},{"issue":"3","key":"5803_CR86","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1111\/j.1471-4159.2005.03076.x","volume":"94","author":"O Masmoudi","year":"2005","unstructured":"Masmoudi O, Gandolfo P, Tokay T et al (2005) Somatostatin down-regulates the expression and release of endozepines from cultured rat astrocytes via distinct receptor subtypes. J Neurochem 94(3):561\u2013571. https:\/\/doi.org\/10.1111\/j.1471-4159.2005.03076.x","journal-title":"J Neurochem"},{"key":"5803_CR87","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.nbd.2015.12.009","volume":"87","author":"C Buren","year":"2016","unstructured":"Buren C, Parsons MP, Smith-Dijak A et al (2016) Impaired development of cortico-striatal synaptic connectivity in a cell culture model of Huntington\u2019s disease. Neurobiol Dis 87:80\u201390. https:\/\/doi.org\/10.1016\/j.nbd.2015.12.009","journal-title":"Neurobiol Dis"},{"key":"5803_CR88","doi-asserted-by":"publisher","DOI":"10.1523\/jneurosci.0598-23.2024","author":"T Riedemann","year":"2024","unstructured":"Riedemann T, Sutor B (2024) Cell-Type\u2013Specific Effects of Somatostatin on Synaptic Transmission in the Anterior Cingulate Cortex. J Neurosci. https:\/\/doi.org\/10.1523\/jneurosci.0598-23.2024","journal-title":"J Neurosci"},{"key":"5803_CR89","doi-asserted-by":"publisher","DOI":"10.1007\/s44202-024-00223-5","author":"X Li","year":"2024","unstructured":"Li X (2024) Unravelling the role of SHANK3 mutations in targeted therapies for autism spectrum disorders. Discover Psychology. https:\/\/doi.org\/10.1007\/s44202-024-00223-5","journal-title":"Discover Psychology"},{"key":"5803_CR90","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2024.122457","volume":"340","author":"C Zhang","year":"2024","unstructured":"Zhang C, Qi H, Jia D et al (2024) Cognitive impairment in Alzheimer\u2019s disease FAD4T mouse model: synaptic loss facilitated by activated microglia via C1qA. Life Sci 340:122457. https:\/\/doi.org\/10.1016\/j.lfs.2024.122457","journal-title":"Life Sci"},{"key":"5803_CR91","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-019-1386-7","author":"K Kucharava","year":"2019","unstructured":"Kucharava K, Sekulic-Jablanovic M, Horvath L et al (2019) Pasireotide protects mammalian cochlear hair cells from gentamicin ototoxicity by activating the PI3K\u2013Akt pathway. Cell Death Dis. https:\/\/doi.org\/10.1038\/s41419-019-1386-7","journal-title":"Cell Death Dis"},{"key":"5803_CR92","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1016\/j.jconrel.2023.07.008","volume":"360","author":"P Xu","year":"2023","unstructured":"Xu P, Li T-T, Wang B-C et al (2023) Supramolecular assemblies with spatio-temporal sequential drug delivery capability treat spinal cord injury via neuroprotection and immunoregulation. J Control Release 360:528\u2013548. https:\/\/doi.org\/10.1016\/j.jconrel.2023.07.008","journal-title":"J Control Release"},{"issue":"8","key":"5803_CR93","doi-asserted-by":"publisher","first-page":"5525","DOI":"10.1007\/s12035-024-03920-3","volume":"61","author":"J Lv","year":"2024","unstructured":"Lv J, Wang Z, Wang B et al (2024) S100A9 Induces Macrophage M2 Polarization and Immunomodulatory Role in the Lesion Site After Spinal Cord Injury in Rats. Mol Neurobiol 61(8):5525\u20135540. https:\/\/doi.org\/10.1007\/s12035-024-03920-3","journal-title":"Mol Neurobiol"},{"issue":"9","key":"5803_CR94","doi-asserted-by":"publisher","first-page":"6675","DOI":"10.1007\/s12035-024-03956-5","volume":"61","author":"C Wu","year":"2024","unstructured":"Wu C, Ji C, Qian D et al (2024) Contribution of ApoB-100\/SORT1-Mediated Immune Microenvironment in Regulating Oxidative Stress, Inflammation, and Ferroptosis After Spinal Cord Injury. Mol Neurobiol 61(9):6675\u20136687. https:\/\/doi.org\/10.1007\/s12035-024-03956-5","journal-title":"Mol Neurobiol"},{"issue":"5","key":"5803_CR95","doi-asserted-by":"publisher","first-page":"2144","DOI":"10.1210\/jcem.86.5.7487","volume":"86","author":"I Chatzistamou","year":"2001","unstructured":"Chatzistamou I, Schally AV, Varga JL et al (2001) Antagonists of growth hormone-releasing hormone and somatostatin analog RC-160 inhibit the growth of the OV-1063 human epithelial ovarian cancer cell line xenografted into nude mice. J Clin Endocrinol Metab 86(5):2144\u20132152. https:\/\/doi.org\/10.1210\/jcem.86.5.7487","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"5803_CR96","doi-asserted-by":"publisher","first-page":"1794","DOI":"10.1073\/pnas.95.4.1794","volume":"95","author":"A Nagy","year":"1998","unstructured":"Nagy A, Schally AV, Halmos G et al (1998) Synthesis and biological evaluation of cytotoxic analogs of somatostatin containing doxorubicin or its intensely potent derivative, 2-pyrrolinodoxorubicin. Proc Natl Acad Sci 95(4):1794\u20131799. https:\/\/doi.org\/10.1073\/pnas.95.4.1794","journal-title":"Proc Natl Acad Sci"},{"issue":"5","key":"5803_CR97","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1159\/000350468","volume":"20","author":"S Spitsin","year":"2013","unstructured":"Spitsin S, Tuluc F, Meshki J et al (2013) Analog of somatostatin vapreotide exhibits biological effects in vitro via interaction with neurokinin-1 receptor. NeuroImmunoModulation 20(5):247\u2013255. https:\/\/doi.org\/10.1159\/000350468","journal-title":"NeuroImmunoModulation"},{"issue":"1","key":"5803_CR98","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/S0969-8051(96)00180-1","volume":"24","author":"ML Thakur","year":"1997","unstructured":"Thakur ML, Kolan H, Li J et al (1997) Radiolabeled somatostatin analogs in prostate cancer. Nucl Med Biol 24(1):105\u2013113. https:\/\/doi.org\/10.1016\/S0969-8051(96)00180-1","journal-title":"Nucl Med Biol"},{"key":"5803_CR99","doi-asserted-by":"publisher","DOI":"10.1007\/s13311-020-00892-9","author":"X Tao","year":"2020","unstructured":"Tao X, Lee MS, Donnelly CR et al (2020) Neuromodulation, specialized proresolving mediators, and resolution of pain. Neurotherapeutics. https:\/\/doi.org\/10.1007\/s13311-020-00892-9","journal-title":"Neurotherapeutics"},{"key":"5803_CR100","doi-asserted-by":"publisher","DOI":"10.1177\/03000605241245293","author":"D Jiao","year":"2024","unstructured":"Jiao D, Xu Y, Tian F et al (2024) Establishment of animal models and behavioral studies for autism spectrum disorders. J Int Med Res. https:\/\/doi.org\/10.1177\/03000605241245293","journal-title":"J Int Med Res"},{"issue":"1","key":"5803_CR101","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1007\/s12035-024-04305-2","volume":"62","author":"S Bordbar","year":"2024","unstructured":"Bordbar S, Alijanzadeh D, Samieefar N et al (2024) The Role of Alpha-Synuclein in Neurodevelopmental Diseases. Mol Neurobiol 62(1):962\u2013972. https:\/\/doi.org\/10.1007\/s12035-024-04305-2","journal-title":"Mol Neurobiol"},{"issue":"6","key":"5803_CR102","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1038\/s41593-018-0143-z","volume":"21","author":"AG Khan","year":"2018","unstructured":"Khan AG, Poort J, Chadwick A et al (2018) Distinct learning-induced changes in stimulus selectivity and interactions of GABAergic interneuron classes in visual cortex. Nat Neurosci 21(6):851\u2013859. https:\/\/doi.org\/10.1038\/s41593-018-0143-z","journal-title":"Nat Neurosci"},{"issue":"11","key":"5803_CR103","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1038\/s41386-024-01869-4","volume":"49","author":"Y-G Dong","year":"2024","unstructured":"Dong Y-G, Gan Y, Fu Y et al (2024) Treadmill exercise training inhibits morphine CPP by reversing morphine effects on GABA neurotransmission in D2-MSNs of the accumbens-pallidal pathway in male mice. Neuropsychopharmacology 49(11):1700\u20131710. https:\/\/doi.org\/10.1038\/s41386-024-01869-4","journal-title":"Neuropsychopharmacology"},{"key":"5803_CR104","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.brainresbull.2019.06.009","volume":"150","author":"J Yanai","year":"2019","unstructured":"Yanai J, Vigoda MJ, Ornoy A (2019) Reversal of neurobehavioral teratogenicity in animal models and human: three decades of progress. Brain Res Bull 150:328\u2013342. https:\/\/doi.org\/10.1016\/j.brainresbull.2019.06.009","journal-title":"Brain Res Bull"},{"key":"5803_CR105","doi-asserted-by":"publisher","DOI":"10.1016\/b978-0-12-801238-3.97143-5","author":"B Furman","year":"2018","unstructured":"Furman B (2018) Somatostatin Receptor Agents. Reference Module in Biomedical Sciences. https:\/\/doi.org\/10.1016\/b978-0-12-801238-3.97143-5","journal-title":"Reference Module in Biomedical Sciences"},{"key":"5803_CR106","doi-asserted-by":"publisher","DOI":"10.1210\/jendso\/bvaa046.546","author":"P Dasgupta","year":"2020","unstructured":"Dasgupta P, Schulz S (2020) SAT-305 veldoreotide (COR005) mechanisms of action studies: comparison to octreotide and pasireotide. J Endocr Soc. https:\/\/doi.org\/10.1210\/jendso\/bvaa046.546","journal-title":"J Endocr Soc"},{"key":"5803_CR107","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.mce.2005.11.002","volume":"247","author":"XP Wang","year":"2006","unstructured":"Wang XP, Norman M, Yang J et al (2006) Alterations in glucose homeostasis in SSTR1 gene-ablated mice. Mol Cell Endocrinol 247:82\u201390. https:\/\/doi.org\/10.1016\/j.mce.2005.11.002","journal-title":"Mol Cell Endocrinol"},{"issue":"3","key":"5803_CR108","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1007\/s00441-014-1977-7","volume":"358","author":"V Radojevic","year":"2014","unstructured":"Radojevic V, Bodmer D (2014) Expression and localization of somatostatin receptor types 3, 4 and 5 in the wild-type, SSTR1 and SSTR1\/SSTR2 knockout mouse cochlea. Cell Tissue Res 358(3):717\u2013727. https:\/\/doi.org\/10.1007\/s00441-014-1977-7","journal-title":"Cell Tissue Res"},{"issue":"3","key":"5803_CR109","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1007\/s12031-012-9792-7","volume":"48","author":"U Kumar","year":"2012","unstructured":"Kumar U (2012) Immunohistochemical distribution of somatostatin and somatostatin receptor subtypes (SSTR1\u20135) in hypothalamus of ApoD knockout mice brain. J Mol Neurosci 48(3):684\u2013695. https:\/\/doi.org\/10.1007\/s12031-012-9792-7","journal-title":"J Mol Neurosci"},{"key":"5803_CR110","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.mce.2004.02.001","volume":"221","author":"JL Ram\u0131\u0301rez","year":"2004","unstructured":"Ram\u0131\u0301rez JL, Grant M, Norman M et al (2004) Deficiency of somatostatin (SST) receptor type 5 (SSTR5) is associated with sexually dimorphic changes in the expression of SST and SST receptors in brain and pancreas. Mol Cell Endocrinol 221:105\u2013119. https:\/\/doi.org\/10.1016\/j.mce.2004.02.001","journal-title":"Mol Cell Endocrinol"},{"key":"5803_CR111","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22073758","author":"B Nemes","year":"2021","unstructured":"Nemes B, B\u00f6lcskei K, Kecsk\u00e9s A et al (2021) Human somatostatin SST(4) receptor transgenic mice: construction and brain expression pattern characterization. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms22073758","journal-title":"Int J Mol Sci"},{"key":"5803_CR112","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2024.114753","volume":"376","author":"M Ruscu","year":"2024","unstructured":"Ruscu M, Glavan D, Surugiu R et al (2024) Pharmacological and stem cell therapy of stroke in animal models: do they accurately reflect the response of humans? Exp Neurol 376:114753. https:\/\/doi.org\/10.1016\/j.expneurol.2024.114753","journal-title":"Exp Neurol"},{"key":"5803_CR113","doi-asserted-by":"publisher","unstructured":"I. E. Monosov, J. Zimmermann, M. J. Frank et al. Ethological computational psychiatry: Challenges and opportunities. Current Opinion in Neurobiology. 2024; 86102881. https:\/\/doi.org\/10.1016\/j.conb.2024.102881","DOI":"10.1016\/j.conb.2024.102881"},{"issue":"12","key":"5803_CR114","doi-asserted-by":"publisher","DOI":"10.3390\/ph17121631","volume":"17","author":"IR Popa Ilie","year":"2024","unstructured":"Popa Ilie IR, Dobrea CM, Butuca A et al (2024) Real-life data on the safety of pasireotide in acromegaly: insights from EudraVigilance. Pharmaceuticals 17(12):1631. https:\/\/doi.org\/10.3390\/ph17121631","journal-title":"Pharmaceuticals"},{"issue":"1","key":"5803_CR115","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s40618-023-02170-9","volume":"47","author":"A Faggiano","year":"2023","unstructured":"Faggiano A (2023) Long-acting somatostatin analogs and well differentiated neuroendocrine tumors: a 20-year-old story. J Endocrinol Invest 47(1):35\u201346. https:\/\/doi.org\/10.1007\/s40618-023-02170-9","journal-title":"J Endocrinol Invest"},{"issue":"4","key":"5803_CR116","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1590\/1806-9282.20211224","volume":"68","author":"E Gezer","year":"2022","unstructured":"Gezer E, Demirhan Y, Selek A et al (2022) Comparison between somatostatin analog injections. Rev Assoc Med Bras 68(4):514\u2013518. https:\/\/doi.org\/10.1590\/1806-9282.20211224","journal-title":"Rev Assoc Med Bras"},{"issue":"1","key":"5803_CR117","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s40618-022-01875-7","volume":"46","author":"JE Machado-Alba","year":"2022","unstructured":"Machado-Alba JE, Machado-Duque ME, Gaviria-Mendoza A et al (2022) Prescription patterns of somatostatin analogs in patients with acromegaly and neuroendocrine tumors. J Endocrinol Invest 46(1):27\u201335. https:\/\/doi.org\/10.1007\/s40618-022-01875-7","journal-title":"J Endocrinol Invest"},{"key":"5803_CR118","doi-asserted-by":"publisher","DOI":"10.1016\/j.wneu.2019.01.125","author":"S-C Shen","year":"2019","unstructured":"Shen S-C, Shen C-C, Pu T-W, Cheng W-Y (2019) Long-term effects of intracapsular debulking and adjuvant somatostatin analogs for growth hormone-secreting pituitary macroadenoma: 10 years of experience in a single institute. World Neurosurg. https:\/\/doi.org\/10.1016\/j.wneu.2019.01.125","journal-title":"World Neurosurg"},{"issue":"11","key":"5803_CR119","doi-asserted-by":"publisher","first-page":"1846","DOI":"10.1093\/annonc\/mdz219","volume":"30","author":"MH Kulke","year":"2019","unstructured":"Kulke MH, Ruszniewski P, Van Cutsem E et al (2019) A randomized, open-label, phase 2 study of everolimus in combination with pasireotide LAR or everolimus alone in advanced, well-differentiated, progressive pancreatic neuroendocrine tumors: COOPERATE-2 trial. Ann Oncol 30(11):1846. https:\/\/doi.org\/10.1093\/annonc\/mdz219","journal-title":"Ann Oncol"},{"issue":"11","key":"5803_CR120","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1016\/s2468-1253(21)00262-4","volume":"6","author":"L Goltstein","year":"2021","unstructured":"Goltstein L, Grooteman KV, Rocco A et al (2021) Effectiveness and predictors of response to somatostatin analogues in patients with gastrointestinal angiodysplasias: a systematic review and individual patient data meta-analysis. Lancet Gastroenterol Hepatol 6(11):922\u2013932. https:\/\/doi.org\/10.1016\/s2468-1253(21)00262-4","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"4","key":"5803_CR121","doi-asserted-by":"publisher","first-page":"315","DOI":"10.3390\/livers2040024","volume":"2","author":"E Kouroumalis","year":"2022","unstructured":"Kouroumalis E, Tsomidis I, Voumvouraki A (2022) Is there a place for somatostatin analogues for the systemic treatment of hepatocellular carcinoma in the immunotherapy era? Livers 2(4):315\u2013335. https:\/\/doi.org\/10.3390\/livers2040024","journal-title":"Livers"},{"issue":"5","key":"5803_CR122","doi-asserted-by":"publisher","first-page":"4793","DOI":"10.3390\/ijms24054793","volume":"24","author":"SE Tollefsen","year":"2023","unstructured":"Tollefsen SE, Solheim O, Mj\u00f8nes P et al (2023) Meningiomas and Somatostatin Analogs: A Systematic Scoping Review on Current Insights and Future Perspectives. Int J Mol Sci 24(5):4793. https:\/\/doi.org\/10.3390\/ijms24054793","journal-title":"Int J Mol Sci"},{"issue":"3","key":"5803_CR123","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1007\/s12022-020-09647-w","volume":"32","author":"T Nakano-Tateno","year":"2020","unstructured":"Nakano-Tateno T, Satou M, Inoshita N et al (2020) Effects of CAPTEM (Capecitabine and Temozolomide) on a Corticotroph Carcinoma and an Aggressive Corticotroph Tumor. Endocr Pathol 32(3):418\u2013426. https:\/\/doi.org\/10.1007\/s12022-020-09647-w","journal-title":"Endocr Pathol"},{"issue":"3","key":"5803_CR124","doi-asserted-by":"publisher","first-page":"274","DOI":"10.31662\/jmaj.2022-0219","volume":"6","author":"WJS Hirono","year":"2023","unstructured":"Hirono WJS, Miki A, Shiozawa M et al (2023) The Efficacy and Safety of Somatostatin Analog after Axillary Node Dissection in Breast Cancer: A Systematic Review and Meta-analysis. JMA Journal 6(3):274\u2013281. https:\/\/doi.org\/10.31662\/jmaj.2022-0219","journal-title":"JMA Journal"},{"key":"5803_CR125","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2025.178053","volume":"1005","author":"W Ye","year":"2025","unstructured":"Ye W, Liu Z (2025) Real-world drug safety study of somatostatin analogs based on the food and drug administration adverse event reporting system database. Eur J Pharmacol 1005:178053. https:\/\/doi.org\/10.1016\/j.ejphar.2025.178053","journal-title":"Eur J Pharmacol"},{"key":"5803_CR126","doi-asserted-by":"publisher","DOI":"10.1016\/j.envint.2024.108462","volume":"184","author":"A Armenta-Castro","year":"2024","unstructured":"Armenta-Castro A, N\u00fa\u00f1ez-Soto MT, Rodriguez-Aguill\u00f3n KO et al (2024) Urine biomarkers for Alzheimer\u2019s disease: a new opportunity for wastewater-based epidemiology? Environ Int 184:108462. https:\/\/doi.org\/10.1016\/j.envint.2024.108462","journal-title":"Environ Int"},{"issue":"1","key":"5803_CR127","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1007\/s00406-024-01827-7","volume":"275","author":"Y Feng","year":"2024","unstructured":"Feng Y, Laraib A, Lin X, Li Q et al (2024) Associations of tau, A\u03b2, and brain volume of the Papez circuit with cognition in Alzheimer\u2019s disease. Eur Arch Psychiatry Clin Neurosci 275(1):241\u2013256. https:\/\/doi.org\/10.1007\/s00406-024-01827-7","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"issue":"1","key":"5803_CR128","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2022.105678","volume":"26","author":"K-L Hsieh","year":"2023","unstructured":"Hsieh K-L, Plascencia-Villa G, Lin K-H et al (2023) Synthesize heterogeneous biological knowledge via representation learning for Alzheimer\u2019s disease drug repurposing. iScience 26(1):105678. https:\/\/doi.org\/10.1016\/j.isci.2022.105678","journal-title":"iScience"},{"key":"5803_CR129","doi-asserted-by":"publisher","unstructured":"C. Yan, M. E. Grabowska, A. L. Dickson et al. Leveraging generative AI to prioritize drug repurposing candidates for Alzheimer\u2019s disease with real-world clinical validation. npj Digital Medicine. 2024; 7(1):https:\/\/doi.org\/10.1038\/s41746-024-01038-3","DOI":"10.1038\/s41746-024-01038-3"},{"key":"5803_CR130","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2024.108751","volume":"264","author":"L Gao","year":"2024","unstructured":"Gao L, Yang X-N, Dong Y-X et al (2024) The potential therapeutic strategy in combating neurodegenerative diseases: focusing on natural products. Pharmacol Ther 264:108751. https:\/\/doi.org\/10.1016\/j.pharmthera.2024.108751","journal-title":"Pharmacol Ther"},{"issue":"7","key":"5803_CR131","doi-asserted-by":"publisher","first-page":"1876","DOI":"10.1007\/s00259-024-06631-y","volume":"51","author":"M Cotta Ramusino","year":"2024","unstructured":"Cotta Ramusino M, Massa F, Festari C et al (2024) Diagnostic performance of molecular imaging methods in predicting the progression from mild cognitive impairment to dementia: an updated systematic review. European Journal of Nuclear Medicine and Molecular Imaging 51(7):1876\u20131890. https:\/\/doi.org\/10.1007\/s00259-024-06631-y","journal-title":"European Journal of Nuclear Medicine and Molecular Imaging"},{"issue":"11","key":"5803_CR132","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1007\/s00415-007-0539-2","volume":"254","author":"S Veps\u00e4l\u00e4inen","year":"2007","unstructured":"Veps\u00e4l\u00e4inen S, Helisalmi S, Koivisto AM et al (2007) Somatostatin genetic variants modify the risk for Alzheimer\u2019s disease among Finnish patients. J Neurol 254(11):1504\u20131508. https:\/\/doi.org\/10.1007\/s00415-007-0539-2","journal-title":"J Neurol"},{"key":"5803_CR133","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2023.176251","volume":"962","author":"K Chen","year":"2024","unstructured":"Chen K, Yu G (2024) Tetrahydroalstonine possesses protective potentials on palmitic acid stimulated SK-N-MC cells by suppression of A\u03b21-42 and tau through regulation of PI3K\/Akt signaling pathway. Eur J Pharmacol 962:176251. https:\/\/doi.org\/10.1016\/j.ejphar.2023.176251","journal-title":"Eur J Pharmacol"},{"key":"5803_CR134","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2024.108606","volume":"255","author":"Y You","year":"2024","unstructured":"You Y, Chen Z, Hu W-W (2024) The role of microglia heterogeneity in synaptic plasticity and brain disorders: will sequencing shed light on the discovery of new therapeutic targets? Pharmacol Ther 255:108606. https:\/\/doi.org\/10.1016\/j.pharmthera.2024.108606","journal-title":"Pharmacol Ther"},{"key":"5803_CR135","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbr.2024.114889","volume":"463","author":"W Zheng","year":"2024","unstructured":"Zheng W, Li K, Zhong M et al (2024) Mitophagy activation by rapamycin enhances mitochondrial function and cognition in 5\u00d7FAD mice. Behav Brain Res 463:114889. https:\/\/doi.org\/10.1016\/j.bbr.2024.114889","journal-title":"Behav Brain Res"},{"issue":"1","key":"5803_CR136","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s13311-022-01308-6","volume":"20","author":"L S\u00f6derberg","year":"2023","unstructured":"S\u00f6derberg L, Johannesson M, Nygren P et al (2023) Lecanemab, Aducanumab, and Gantenerumab - Binding Profiles to Different Forms of Amyloid-Beta Might Explain Efficacy and Side Effects in Clinical Trials for Alzheimer\u2019s Disease. Neurotherapeutics 20(1):195\u2013206. https:\/\/doi.org\/10.1007\/s13311-022-01308-6","journal-title":"Neurotherapeutics"},{"issue":"10","key":"5803_CR137","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1007\/s40265-024-02087-4","volume":"84","author":"C Kang","year":"2024","unstructured":"Kang C (2024) Donanemab: First Approval. Drugs 84(10):1313\u20131318. https:\/\/doi.org\/10.1007\/s40265-024-02087-4","journal-title":"Drugs"},{"key":"5803_CR138","unstructured":"Aducanumab (Aduhelm) for Alzheimer's disease. Med Lett Drugs Ther. 2021;63(1628):105\u2013106"},{"key":"5803_CR139","doi-asserted-by":"publisher","DOI":"10.3390\/jpm15090437","author":"AE Alkhalifa","year":"2025","unstructured":"Alkhalifa AE, Al Mokhlf A, Ali H et al (2025) Anti-amyloid monoclonal antibodies for Alzheimer\u2019s disease: evidence, ARIA risk, and precision patient selection. J Pers Med. https:\/\/doi.org\/10.3390\/jpm15090437","journal-title":"J Pers Med"},{"issue":"10","key":"5803_CR140","doi-asserted-by":"publisher","first-page":"1742","DOI":"10.1093\/neuonc\/noae082","volume":"26","author":"JZ Wang","year":"2024","unstructured":"Wang JZ, Landry AP, Raleigh DR et al (2024) Meningioma: International Consortium on Meningiomas consensus review on scientific advances and treatment paradigms for clinicians, researchers, and patients. Neuro Oncol 26(10):1742\u20131780. https:\/\/doi.org\/10.1093\/neuonc\/noae082","journal-title":"Neuro Oncol"},{"issue":"9","key":"5803_CR141","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1007\/s00761-020-00817-3","volume":"26","author":"P Kies","year":"2020","unstructured":"Kies P, Stegger L, Weckesser M, Rahbar K (2020) Lokale Therapieverfahren neuroendokriner Tumoren mit dem Schwerpunkt nuklearmedizinische Optionen. Onkologe 26(9):816\u2013825. https:\/\/doi.org\/10.1007\/s00761-020-00817-3","journal-title":"Onkologe"},{"key":"5803_CR142","doi-asserted-by":"publisher","DOI":"10.1007\/s12031-024-02221-7","author":"Y Hu","year":"2024","unstructured":"Hu Y, Zhao Z, Xu F et al (2024) Transcriptome and animal model integration reveals inhibition of calcium homeostasis-associated gene ITPKB alleviates amyloid plaque deposition. J Mol Neurosci. https:\/\/doi.org\/10.1007\/s12031-024-02221-7","journal-title":"J Mol Neurosci"},{"key":"5803_CR143","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.sajb.2024.01.001","volume":"165","author":"K Fatima","year":"2024","unstructured":"Fatima K, Ashfaq UA, Tahir ul Qamar M et al (2024) Advanced network pharmacology and molecular docking-based mechanism study to explore the multi-target pharmacological mechanism of Cymbopogon citratus against Alzheimer\u2019s disease. S Afr J Bot 165:466\u2013477. https:\/\/doi.org\/10.1016\/j.sajb.2024.01.001","journal-title":"S Afr J Bot"},{"key":"5803_CR144","doi-asserted-by":"publisher","DOI":"10.1016\/j.patcog.2024.110423","volume":"153","author":"B Lei","year":"2024","unstructured":"Lei B, Liang Y, Xie J et al (2024) Hybrid federated learning with brain-region attention network for multi-center Alzheimer\u2019s disease detection. Pattern Recognit 153:110423. https:\/\/doi.org\/10.1016\/j.patcog.2024.110423","journal-title":"Pattern Recognit"},{"key":"5803_CR145","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.neurobiolaging.2023.12.003","volume":"135","author":"F Levin","year":"2024","unstructured":"Levin F, Grothe MJ, Dyrba M, Franzmeier N, Teipel SJ (2024) Longitudinal trajectories of cognitive reserve in hypometabolic subtypes of Alzheimer\u2019s disease. Neurobiol Aging 135:26\u201338. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2023.12.003","journal-title":"Neurobiol Aging"},{"key":"5803_CR146","doi-asserted-by":"publisher","DOI":"10.1038\/s41420-023-01778-3","author":"T Zhang","year":"2024","unstructured":"Zhang T, Lei H, Chen X et al (2024) Carrier systems of radiopharmaceuticals and the application in cancer therapy. Cell Death Discov. https:\/\/doi.org\/10.1038\/s41420-023-01778-3","journal-title":"Cell Death Discov"},{"issue":"6","key":"5803_CR147","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/s1000-1948(09)60008-3","volume":"23","author":"W Song","year":"2008","unstructured":"Song W, Qingmo L, Duanfang L (2008) Nonpeptide somatostatin analogs: recent advances in its application and research. Journal of Medical Colleges of PLA 23(6):364\u2013376. https:\/\/doi.org\/10.1016\/s1000-1948(09)60008-3","journal-title":"Journal of Medical Colleges of PLA"},{"key":"5803_CR148","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2202-12-89","author":"V Radojevic","year":"2011","unstructured":"Radojevic V, Hanusek C, Setz C et al (2011) The somatostatinergic system in the mammalian cochlea. BMC Neurosci. https:\/\/doi.org\/10.1186\/1471-2202-12-89","journal-title":"BMC Neurosci"},{"issue":"6","key":"5803_CR149","doi-asserted-by":"publisher","first-page":"312","DOI":"10.5732\/cjc.012.10295","volume":"32","author":"C Ro","year":"2013","unstructured":"Ro C, Chai W, Yu VE et al (2013) Pancreatic neuroendocrine tumors: biology, diagnosis,and treatment. Chin J Cancer 32(6):312\u2013324. https:\/\/doi.org\/10.5732\/cjc.012.10295","journal-title":"Chin J Cancer"},{"key":"5803_CR150","doi-asserted-by":"publisher","DOI":"10.1152\/ajpgi.00174.2006","author":"Z Liao","year":"2007","unstructured":"Liao Z, Li Z-S, Lu Y et al (2007) Microinjection of exogenous somatostatin in the dorsal vagal complex inhibits pancreatic secretion via somatostatin receptor-2 in rats. American Journal of Physiology-Gastrointestinal and Liver Physiology. https:\/\/doi.org\/10.1152\/ajpgi.00174.2006","journal-title":"American Journal of Physiology-Gastrointestinal and Liver Physiology"},{"key":"5803_CR151","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2023.104694","volume":"86","author":"A Mishra","year":"2023","unstructured":"Mishra A, Kumar R, Mishra J et al (2023) Strategies facilitating the permeation of nanoparticles through blood-brain barrier: an insight towards the development of brain-targeted drug delivery system. J Drug Deliv Sci Technol 86:104694. https:\/\/doi.org\/10.1016\/j.jddst.2023.104694","journal-title":"J Drug Deliv Sci Technol"},{"key":"5803_CR152","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.jconrel.2023.05.009","volume":"358","author":"J Liao","year":"2023","unstructured":"Liao J, Fan L, Li Y et al (2023) Recent advances in biomimetic nanodelivery systems: new brain-targeting strategies. J Control Release 358:439\u2013464. https:\/\/doi.org\/10.1016\/j.jconrel.2023.05.009","journal-title":"J Control Release"},{"key":"5803_CR153","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-024-03331-3","author":"H Ghaznavi","year":"2024","unstructured":"Ghaznavi H, Afzalipour R, Khoei S et al (2024) New insights into targeted therapy of glioblastoma using smart nanoparticles. Cancer Cell Int. https:\/\/doi.org\/10.1186\/s12935-024-03331-3","journal-title":"Cancer Cell Int"},{"issue":"5","key":"5803_CR154","doi-asserted-by":"publisher","first-page":"245","DOI":"10.3390\/pharmaceutics11050245","volume":"11","author":"A Parodi","year":"2019","unstructured":"Parodi A, Rudzi\u0144ska M, Deviatkin A et al (2019) Established and Emerging Strategies for Drug Delivery Across the Blood-Brain Barrier in Brain Cancer. Pharmaceutics 11(5):245. https:\/\/doi.org\/10.3390\/pharmaceutics11050245","journal-title":"Pharmaceutics"},{"key":"5803_CR155","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.jconrel.2024.03.055","volume":"369","author":"Y Ding","year":"2024","unstructured":"Ding Y, Xu Q, Chai Z et al (2024) All-stage targeted red blood cell membrane-coated docetaxel nanocrystals for glioma treatment. J Control Release 369:325\u2013334. https:\/\/doi.org\/10.1016\/j.jconrel.2024.03.055","journal-title":"J Control Release"},{"issue":"4","key":"5803_CR156","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1038\/s41578-021-00394-w","volume":"7","author":"E Nance","year":"2021","unstructured":"Nance E, Pun SH, Saigal R, Sellers DL (2021) Drug delivery to the central nervous system. Nat Rev Mater 7(4):314\u2013331. https:\/\/doi.org\/10.1038\/s41578-021-00394-w","journal-title":"Nat Rev Mater"},{"key":"5803_CR157","doi-asserted-by":"publisher","DOI":"10.1016\/j.apmt.2024.102194","volume":"38","author":"E Amulya","year":"2024","unstructured":"Amulya E, Bahuguna D, Negi M et al (2024) Lipid engineered nanomaterials: a novel paradigm shift for combating stroke. Appl Mater Today 38:102194. https:\/\/doi.org\/10.1016\/j.apmt.2024.102194","journal-title":"Appl Mater Today"},{"issue":"6","key":"5803_CR158","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2023.188996","volume":"1878","author":"M Ge","year":"2023","unstructured":"Ge M, Zhu Y, Wei M et al (2023) Improving the efficacy of anti-EGFR drugs in GBM: where we are going? Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1878(6):188996. https:\/\/doi.org\/10.1016\/j.bbcan.2023.188996","journal-title":"Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"},{"key":"5803_CR159","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2024.115274","author":"E Perolina","year":"2024","unstructured":"Perolina E, Meissner S, Raos B et al (2024) Translating ultrasound-mediated drug delivery technologies for CNS applications. Adv Drug Deliv Rev. https:\/\/doi.org\/10.1016\/j.addr.2024.115274","journal-title":"Adv Drug Deliv Rev"},{"key":"5803_CR160","doi-asserted-by":"publisher","unstructured":"Q. Huang, Y. Chen, W. Zhang et al. (2024) Nanotechnology for enhanced nose-to-brain drug delivery in treating neurological diseases. Journal of Controlled Release. 366519-534. https:\/\/doi.org\/10.1016\/j.jconrel.2023.12.054","DOI":"10.1016\/j.jconrel.2023.12.054"},{"issue":"12","key":"5803_CR161","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1001\/archpsyc.56.12.1135","volume":"56","author":"S Craft","year":"1999","unstructured":"Craft S, Asthana S, Newcomer JW et al (1999) Enhancement of memory in Alzheimer disease with insulin and somatostatin, but not glucose. Arch Gen Psychiatry 56(12):1135\u20131140. https:\/\/doi.org\/10.1001\/archpsyc.56.12.1135","journal-title":"Arch Gen Psychiatry"},{"issue":"4","key":"5803_CR162","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1038\/nm1206","volume":"11","author":"T Saito","year":"2005","unstructured":"Saito T, Iwata N, Tsubuki S et al (2005) Somatostatin regulates brain amyloid beta peptide Abeta42 through modulation of proteolytic degradation. Nat Med 11(4):434\u2013439. https:\/\/doi.org\/10.1038\/nm1206","journal-title":"Nat Med"},{"issue":"8","key":"5803_CR163","doi-asserted-by":"publisher","DOI":"10.1016\/j.arcmed.2023.102924","volume":"54","author":"M Marques-Pamies","year":"2023","unstructured":"Marques-Pamies M, Gil J, Jord\u00e0 M et al (2023) Predictors of Response to Treatment with First-Generation Somatostatin Receptor Ligands in Patients with Acromegaly. Arch Med Res 54(8):102924. https:\/\/doi.org\/10.1016\/j.arcmed.2023.102924","journal-title":"Arch Med Res"},{"key":"5803_CR164","doi-asserted-by":"publisher","unstructured":"M. Rutherford, M. Wheless, K. Thomas et al. Current and emerging strategies for the management of advanced\/metastatic lung neuroendocrine tumors. Current Problems in Cancer. 2024; 49101061. https:\/\/doi.org\/10.1016\/j.currproblcancer.2024.101061","DOI":"10.1016\/j.currproblcancer.2024.101061"},{"key":"5803_CR165","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.coemr.2021.03.019","volume":"18","author":"WW de Herr","year":"2021","unstructured":"de Herr WW, Feelders RA, Hofland J (2021) Medical treatment of neuroendocrine neoplasms. Curr Opin Endocr Metab Res 18:139\u2013144. https:\/\/doi.org\/10.1016\/j.coemr.2021.03.019","journal-title":"Curr Opin Endocr Metab Res"},{"issue":"2","key":"5803_CR166","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1007\/s12253-018-0426-4","volume":"25","author":"A Zalatnai","year":"2018","unstructured":"Zalatnai A, Galambos E, Perj\u00e9si E (2018) Importance of immunohistochemical detection of somatostatin receptors. Pathol Oncol Res 25(2):521\u2013525. https:\/\/doi.org\/10.1007\/s12253-018-0426-4","journal-title":"Pathol Oncol Res"},{"issue":"3","key":"5803_CR167","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1007\/s12020-020-02329-x","volume":"69","author":"W Alshafie","year":"2020","unstructured":"Alshafie W, Pan YE, Kreienkamp H-J et al (2020) Characterization of agonist-dependent somatostatin receptor subtype 2 trafficking in neuroendocrine cells. Endocrine 69(3):655\u2013669. https:\/\/doi.org\/10.1007\/s12020-020-02329-x","journal-title":"Endocrine"},{"key":"5803_CR168","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2018\/1763735","volume":"2018","author":"F Behling","year":"2018","unstructured":"Behling F, Honegger J, Skardelly M et al (2018) High expression of somatostatin receptors 2A, 3, and 5 in corticotroph pituitary adenoma. Int J Endocrinol 2018:1\u201312. https:\/\/doi.org\/10.1155\/2018\/1763735","journal-title":"Int J Endocrinol"},{"key":"5803_CR169","doi-asserted-by":"publisher","unstructured":"F. A. R. Mota, M. L. C. Passos, J. L. M. Santos et al. S. Saraiva. Comparative analysis of electrochemical and optical sensors for detection of chronic wounds biomarkers: A review. Biosensors and Bioelectronics. 2024; 251116095. https:\/\/doi.org\/10.1016\/j.bios.2024.116095","DOI":"10.1016\/j.bios.2024.116095"},{"key":"5803_CR170","doi-asserted-by":"publisher","first-page":"1","DOI":"10.30683\/1929-2279.2025.14.01","volume":"14","author":"MS Ganesh","year":"2025","unstructured":"Ganesh MS, Revanth R, Elaya Bharathi CM (2025) Advanced biomarkers and precision medicine: innovative strategies to prevent cancer recurrence. Journal of Cancer Research Updates 14:1\u201311. https:\/\/doi.org\/10.30683\/1929-2279.2025.14.01","journal-title":"Journal of Cancer Research Updates"},{"key":"5803_CR171","doi-asserted-by":"publisher","DOI":"10.1155\/emmi\/4585495","author":"N Wang","year":"2025","unstructured":"Wang N, Huang H, Tan Y, Zhang N (2025) Research progress of biomarkers for sepsis and precision medicine. Emerg Med Int. https:\/\/doi.org\/10.1155\/emmi\/4585495","journal-title":"Emerg Med Int"},{"issue":"5","key":"5803_CR172","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1007\/s40291-020-00483-6","volume":"24","author":"ML Marcovecchio","year":"2020","unstructured":"Marcovecchio ML (2020) Importance of identifying novel biomarkers of microvascular damage in type 1 diabetes. Molecular Diagnosis & Therapy 24(5):507\u2013515. https:\/\/doi.org\/10.1007\/s40291-020-00483-6","journal-title":"Molecular Diagnosis & Therapy"},{"issue":"2","key":"5803_CR173","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1159\/000472563","volume":"106","author":"M K\u00f6rner","year":"2017","unstructured":"K\u00f6rner M, Waser B, Christ E et al (2017) A critical evaluation of sst3 and sst5 immunohistochemistry in human pituitary adenomas. Neuroendocrinology 106(2):116\u2013127. https:\/\/doi.org\/10.1159\/000472563","journal-title":"Neuroendocrinology"},{"issue":"17","key":"5803_CR174","doi-asserted-by":"publisher","first-page":"2741","DOI":"10.3390\/diagnostics13172741","volume":"13","author":"D Vogele","year":"2023","unstructured":"Vogele D, Schmidt SA, Gnutzmann D et al (2023) Gastroenteropancreatic Neuroendocrine Tumors\u2014Current Status and Advances in Diagnostic Imaging. Diagnostics 13(17):2741. https:\/\/doi.org\/10.3390\/diagnostics13172741","journal-title":"Diagnostics"},{"key":"5803_CR175","doi-asserted-by":"publisher","DOI":"10.1016\/j.nucmedbio.2024.108905","author":"IV Andersen","year":"2024","unstructured":"Andersen IV, Bidesi NSR, Shalgunov V et al (2024) Investigation of imaging the somatostatin receptor by opening the blood-brain barrier with melittin \u2013 a feasibility study using positron emission tomography and [64Cu]Cu-DOTATATE. Nucl Med Biol. https:\/\/doi.org\/10.1016\/j.nucmedbio.2024.108905","journal-title":"Nucl Med Biol"},{"issue":"5","key":"5803_CR176","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1007\/s12149-017-1163-6","volume":"31","author":"J Kunikowska","year":"2017","unstructured":"Kunikowska J, Pawlak D, B\u0105k MI et al (2017) Long-term results and tolerability of tandem peptide receptor radionuclide therapy with 90Y\/177Lu-DOTATATE in neuroendocrine tumors with respect to the primary location: a 10-year study. Ann Nucl Med 31(5):347\u2013356. https:\/\/doi.org\/10.1007\/s12149-017-1163-6","journal-title":"Ann Nucl Med"},{"key":"5803_CR177","doi-asserted-by":"publisher","unstructured":"A. Healy, E. Ho, P. Kuo, and K. Zukotynski. A brief overview of targeted radionuclide therapy trials in 2022. Frontiers in Nuclear Medicine. 2023;3https:\/\/doi.org\/10.3389\/fnume.2023.1169650","DOI":"10.3389\/fnume.2023.1169650"},{"key":"5803_CR178","doi-asserted-by":"publisher","unstructured":"R. Lenain, A. Hamroun, G. Lion et al. Description of a transient proximal tubulopathy induced by amino acids perfusion in peptide receptor radionuclide therapy. Medicine. 2019;98(52):https:\/\/doi.org\/10.1097\/md.0000000000018478","DOI":"10.1097\/md.0000000000018478"},{"issue":"2","key":"5803_CR179","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1097\/mpa.0000000000000734","volume":"46","author":"N Sharma","year":"2017","unstructured":"Sharma N, Naraev BG, Engelman EG et al (2017) Peptide Receptor Radionuclide Therapy Outcomes in a North American Cohort With Metastatic Well-Differentiated Neuroendocrine Tumors. Pancreas 46(2):151\u2013156. https:\/\/doi.org\/10.1097\/mpa.0000000000000734","journal-title":"Pancreas"},{"issue":"8","key":"5803_CR180","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1038\/s41379-018-0010-1","volume":"31","author":"Y Arvidsson","year":"2018","unstructured":"Arvidsson Y, Rehammar A, Bergstr\u00f6m A et al (2018) miRNA profiling of small intestinal neuroendocrine tumors defines novel molecular subtypes and identifies miR-375 as a biomarker of patient survival. Mod Pathol 31(8):1302\u20131317. https:\/\/doi.org\/10.1038\/s41379-018-0010-1","journal-title":"Mod Pathol"},{"issue":"2","key":"5803_CR181","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/s11377-020-00428-9","volume":"15","author":"H Lahner","year":"2020","unstructured":"Lahner H, F\u00fchrer D (2020) Neuroendokrine Neoplasien des Gastrointestinaltrakts. Gastroenterologe 15(2):129\u2013141. https:\/\/doi.org\/10.1007\/s11377-020-00428-9","journal-title":"Gastroenterologe"},{"issue":"10","key":"5803_CR182","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1038\/s43587-024-00683-3","volume":"4","author":"CMS Herzog","year":"2024","unstructured":"Herzog CMS, Goeminne LJE et al (2024) Challenges and recommendations for the translation of biomarkers of aging. Nat Aging 4(10):1372\u20131383. https:\/\/doi.org\/10.1038\/s43587-024-00683-3","journal-title":"Nat Aging"},{"issue":"15","key":"5803_CR183","doi-asserted-by":"publisher","first-page":"3016","DOI":"10.1093\/cvr\/cvab370","volume":"118","author":"J van der Velden","year":"2022","unstructured":"van der Velden J, Asselbergs FW, Bakkers J et al (2022) Animal models and animal-free innovations for cardiovascular research: current status and routes to be explored. Consensus document of the ESC Working Group on Myocardial Function and the ESC Working Group on Cellular Biology of the Heart. Cardiovasc Res 118(15):3016\u20133051. https:\/\/doi.org\/10.1093\/cvr\/cvab370","journal-title":"Cardiovasc Res"},{"issue":"6","key":"5803_CR184","doi-asserted-by":"publisher","first-page":"2650","DOI":"10.1038\/s41380-022-01532-8","volume":"27","author":"KJ Parker","year":"2022","unstructured":"Parker KJ (2022) Leveraging a translational research approach to drive diagnostic and treatment advances for autism. Mol Psychiatry 27(6):2650\u20132658. https:\/\/doi.org\/10.1038\/s41380-022-01532-8","journal-title":"Mol Psychiatry"},{"issue":"2","key":"5803_CR185","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1007\/s13311-020-00838-1","volume":"17","author":"P Myserlis","year":"2020","unstructured":"Myserlis P, Radmanesh F, Anderson CD (2020) Translational genomics in neurocritical care: a review. Neurotherapeutics 17(2):563\u2013580. https:\/\/doi.org\/10.1007\/s13311-020-00838-1","journal-title":"Neurotherapeutics"},{"key":"5803_CR186","doi-asserted-by":"publisher","unstructured":"G. Lavertu, E. Diendere, F. L\u00e9gar\u00e9 et al. Fostering translational research in chronic disease management: a logic model proposal. Translational Medicine Communications. 2022; 7(1):https:\/\/doi.org\/10.1186\/s41231-022-00118-4","DOI":"10.1186\/s41231-022-00118-4"},{"key":"5803_CR187","first-page":"2025","volume":"369\u2013403","author":"S Pandey","year":"2025","unstructured":"Pandey S, Pai SRK (2025) Animal models for clinical evaluation. Targeted Therapy for the Central Nervous System 369\u2013403:2025","journal-title":"Targeted Therapy for the Central Nervous System"},{"key":"5803_CR188","unstructured":"J. Li, M. Deng, P. Chen et al. Chapter 1 Animal Models of Chronic Obstructive Pulmonary Disease. null. 2018."},{"key":"5803_CR189","unstructured":"L. Yi-Jiang, X. Wen-Xian, Z. Ling et al. Application of Primates in Human Nervous System Diseases Animal Models Research. PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS. 2022."},{"issue":"20","key":"5803_CR190","doi-asserted-by":"publisher","first-page":"6127","DOI":"10.3390\/jcm11206127","volume":"11","author":"F Panzuto","year":"2022","unstructured":"Panzuto F, Ricci C, Rinzivillo M et al (2022) The Antiproliferative Activity of High-Dose Somatostatin Analogs in Gastro-Entero-Pancreatic Neuroendocrine Tumors: A Systematic Review and Meta-Analysis. J Clin Med 11(20):6127. https:\/\/doi.org\/10.3390\/jcm11206127","journal-title":"J Clin Med"},{"key":"5803_CR191","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.562505","author":"S Zanini","year":"2020","unstructured":"Zanini S, Renzi S, Giovinazzo F et al (2020) mTOR pathway in gastroenteropancreatic neuroendocrine tumor (GEP-NETs). Front Endocrinol. https:\/\/doi.org\/10.3389\/fendo.2020.562505","journal-title":"Front Endocrinol"},{"issue":"4","key":"5803_CR192","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1080\/14740338.2021.1881478","volume":"20","author":"F Panzuto","year":"2021","unstructured":"Panzuto F, Magi L, Rinzivillo M (2021) Exocrine pancreatic insufficiency and somatostatin analogs in patients with neuroendocrine neoplasia. Expert Opin Drug Saf 20(4):383\u2013386. https:\/\/doi.org\/10.1080\/14740338.2021.1881478","journal-title":"Expert Opin Drug Saf"},{"issue":"7","key":"5803_CR193","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.3390\/jcm8071032","volume":"8","author":"L Carideo","year":"2019","unstructured":"Carideo L, Prosperi D, Panzuto F et al (2019) Role of Combined [68Ga]Ga-DOTA-SST Analogues and [18F]FDG PET\/CT in the Management of GEP-NENs: A Systematic Review. J Clin Med 8(7):1032. https:\/\/doi.org\/10.3390\/jcm8071032","journal-title":"J Clin Med"},{"issue":"10","key":"5803_CR194","doi-asserted-by":"publisher","first-page":"3368","DOI":"10.3390\/jcm9103368","volume":"9","author":"F B\u00f6sch","year":"2020","unstructured":"B\u00f6sch F, Altendorf-Hofmann A, Jacob S et al (2020) Distinct Expression Patterns of VEGFR 1\u20133 in Gastroenteropancreatic Neuroendocrine Neoplasms: Supporting Clinical Relevance, but not a Prognostic Factor. J Clin Med 9(10):3368. https:\/\/doi.org\/10.3390\/jcm9103368","journal-title":"J Clin Med"},{"issue":"3","key":"5803_CR195","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s10928-020-09690-4","volume":"47","author":"R Gomeni","year":"2020","unstructured":"Gomeni R, Xu T, Gao X, Bressolle-Gomeni F (2020) Model based approach for estimating the dosage regimen of indomethacin a potential antiviral treatment of patients infected with SARS CoV-2. J Pharmacokinet Pharmacodyn 47(3):189\u2013198. https:\/\/doi.org\/10.1007\/s10928-020-09690-4","journal-title":"J Pharmacokinet Pharmacodyn"},{"issue":"14","key":"5803_CR196","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20143586","volume":"20","author":"REM Baiden-Amissah","year":"2019","unstructured":"Baiden-Amissah REM, Tuyaerts S (2019) Contribution of aging, obesity, and microbiota on tumor immunotherapy efficacy and toxicity. Int J Mol Sci 20(14):3586. https:\/\/doi.org\/10.3390\/ijms20143586","journal-title":"Int J Mol Sci"},{"issue":"5","key":"5803_CR197","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1007\/s11357-020-00202-3","volume":"42","author":"P Sebastiani","year":"2020","unstructured":"Sebastiani P, Andersen SL, Sweigart B et al (2020) Patterns of multi-domain cognitive aging in participants of the Long Life Family Study. GeroScience 42(5):1335\u20131350. https:\/\/doi.org\/10.1007\/s11357-020-00202-3","journal-title":"GeroScience"},{"issue":"5","key":"5803_CR198","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1007\/s11307-021-01600-5","volume":"23","author":"MA Lodge","year":"2021","unstructured":"Lodge MA, Solnes LB, Chaudhry MA, Wahl RL (2021) Prospective within-patient assessment of the impact of an unlabeled octreotide pre-dose on the biodistribution and tumor uptake of 68Ga DOTATOC as assessed by dynamic whole-body PET in patients with neuroendocrine tumors: implications for diagnosis and therapy. Mol Imaging Biol 23(5):766\u2013774. https:\/\/doi.org\/10.1007\/s11307-021-01600-5","journal-title":"Mol Imaging Biol"},{"issue":"3","key":"5803_CR199","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1080\/14740338.2021.1867097","volume":"20","author":"A Koffas","year":"2020","unstructured":"Koffas A, Toumpanakis C (2020) Comparative safety review of the current therapies for gastroenteropancreatic neuroendocrine tumors. Expert Opin Drug Saf 20(3):321\u2013334. https:\/\/doi.org\/10.1080\/14740338.2021.1867097","journal-title":"Expert Opin Drug Saf"},{"key":"5803_CR200","doi-asserted-by":"publisher","DOI":"10.1188\/16.cjon.e139-e146","author":"P Ryan","year":"2016","unstructured":"Ryan P, Phan A, Adelman D et al (2016) Neuroendocrine tumors and Lanreotide depot: clinical considerations and nurse and patient preferences. Clin J Oncol Nurs. https:\/\/doi.org\/10.1188\/16.cjon.e139-e146","journal-title":"Clin J Oncol Nurs"},{"issue":"4","key":"5803_CR201","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1007\/s12325-022-02060-1","volume":"39","author":"B Harrow","year":"2022","unstructured":"Harrow B, Fagnani F, Nevoret C et al (2022) Patterns of Use and Clinical Outcomes with Long-Acting Somatostatin Analogues for Neuroendocrine Tumors: A Nationwide French Retrospective Cohort Study in the Real-Life Setting. Adv Ther 39(4):1754\u20131771. https:\/\/doi.org\/10.1007\/s12325-022-02060-1","journal-title":"Adv Ther"},{"issue":"10","key":"5803_CR202","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1097\/mpa.0000000000000700","volume":"45","author":"ZR Qian","year":"2016","unstructured":"Qian ZR, Li T, Ter-Minassian M et al (2016) Association Between Somatostatin Receptor Expression and Clinical Outcomes in Neuroendocrine Tumors. Pancreas 45(10):1386\u20131393. https:\/\/doi.org\/10.1097\/mpa.0000000000000700","journal-title":"Pancreas"},{"key":"5803_CR203","doi-asserted-by":"publisher","unstructured":"K. Ni, J. Y. Yang, K. Baeg et al. Association between somatostatin analogues and diabetes mellitus in gastroenteropancreatic neuroendocrine tumor patients: A Surveillance, Epidemiology, and End Results<scp>\u2010Medicare<\/scp> analysis of 5235 patients. Cancer Reports. 2021; 4(5):https:\/\/doi.org\/10.1002\/cnr2.1387","DOI":"10.1002\/cnr2.1387"},{"issue":"2","key":"5803_CR204","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1007\/s00280-018-3734-1","volume":"83","author":"M Pavel","year":"2018","unstructured":"Pavel M, Borson-Chazot F, Cailleux A et al (2018) Octreotide SC depot in patients with acromegaly and functioning neuroendocrine tumors: a phase 2, multicenter study. Cancer Chemother Pharmacol 83(2):375\u2013385. https:\/\/doi.org\/10.1007\/s00280-018-3734-1","journal-title":"Cancer Chemother Pharmacol"},{"issue":"10","key":"5803_CR205","doi-asserted-by":"publisher","first-page":"2575","DOI":"10.1007\/s00432-020-03315-6","volume":"146","author":"T Walter","year":"2020","unstructured":"Walter T, Hawkins NS, Pollock RF et al (2020) Systematic review and network meta-analyses of third-line treatments for metastatic colorectal cancer. J Cancer Res Clin Oncol 146(10):2575\u20132587. https:\/\/doi.org\/10.1007\/s00432-020-03315-6","journal-title":"J Cancer Res Clin Oncol"},{"key":"5803_CR206","doi-asserted-by":"publisher","unstructured":"A. S. Israr J, Kumar A. Approaches of pre-clinical and clinical trials of repurposed drug. Progress in Molecular Biology and Translational Science. 2024; 259\u2013275. https:\/\/doi.org\/10.1016\/bs.pmbts.2024.03.024","DOI":"10.1016\/bs.pmbts.2024.03.024"},{"issue":"11","key":"5803_CR207","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1016\/s2468-1253(21)00262-4","volume":"6","author":"LCMJ Goltstein","year":"2021","unstructured":"Goltstein LCMJ, Grooteman KV, Rocco A et al (2021) Effectiveness and predictors of response to somatostatin analogues in patients with gastrointestinal angiodysplasias: a systematic review and individual patient data meta-analysis. The Lancet Gastroenterology & Hepatology 6(11):922\u2013932. https:\/\/doi.org\/10.1016\/s2468-1253(21)00262-4","journal-title":"The Lancet Gastroenterology & Hepatology"},{"key":"5803_CR208","doi-asserted-by":"publisher","unstructured":"M. Goomann, X. Jiang, J. Igarashi et al. Receptor based design, synthesis and biology of novel somatostatin analogs. Peptide Science \u2014 Present and Future. 342\u2013345. https:\/\/doi.org\/10.1007\/0-306-46864-6_115","DOI":"10.1007\/0-306-46864-6_115"},{"key":"5803_CR209","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmc.2021.116424","volume":"49","author":"A Ishida","year":"2021","unstructured":"Ishida A, Okabe Y, Matsushita T et al (2021) Design, synthesis, and biological evaluation of novel somatostatin receptor subtype-2 agonists: optimization for potency and risk mitigation of hERG and phospholipidosis. Bioorg Med Chem 49:116424. https:\/\/doi.org\/10.1016\/j.bmc.2021.116424","journal-title":"Bioorg Med Chem"},{"issue":"15","key":"5803_CR210","doi-asserted-by":"publisher","first-page":"4153","DOI":"10.1016\/j.bmc.2017.06.003","volume":"25","author":"T Yamasaki","year":"2017","unstructured":"Yamasaki T, Hirose H, Yamashita T et al (2017) Discovery of novel somatostatin receptor subtype 5 (SSTR5) antagonists: Pharmacological studies and design to improve pharmacokinetic profiles and human Ether-a-go-go-related gene (hERG) inhibition. Bioorg Med Chem 25(15):4153\u20134162. https:\/\/doi.org\/10.1016\/j.bmc.2017.06.003","journal-title":"Bioorg Med Chem"},{"key":"5803_CR211","doi-asserted-by":"publisher","DOI":"10.1002\/ccr3.5650","author":"H Husni","year":"2022","unstructured":"Husni H, Khan SA, Alghaieb B et al (2022) Pasireotide use for the treatment of endogenous hyperinsulinemic hypoglycemia refractory to conventional medical therapy: a case report and review of the literature. Clin Case Rep. https:\/\/doi.org\/10.1002\/ccr3.5650","journal-title":"Clin Case Rep"},{"issue":"2","key":"5803_CR212","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1080\/14737175.2024.2417419","volume":"25","author":"E Lauricella","year":"2024","unstructured":"Lauricella E, Vilisova S, Chaoul N et al (2024) The current status of somatostatin analogs in the treatment of neuroendocrine tumors and future perspectives. Expert Rev Neurother 25(2):245\u2013258. https:\/\/doi.org\/10.1080\/14737175.2024.2417419","journal-title":"Expert Rev Neurother"},{"issue":"16","key":"5803_CR213","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1080\/14656566.2017.1391217","volume":"18","author":"G Mazziotti","year":"2017","unstructured":"Mazziotti G, Mosca A, Frara S et al (2017) Somatostatin analogs in the treatment of neuroendocrine tumors: current and emerging aspects. Expert Opin Pharmacother 18(16):1679\u20131689. https:\/\/doi.org\/10.1080\/14656566.2017.1391217","journal-title":"Expert Opin Pharmacother"},{"issue":"8","key":"5803_CR214","doi-asserted-by":"publisher","first-page":"2592","DOI":"10.3390\/jcm9082592","volume":"9","author":"J Autio","year":"2020","unstructured":"Autio J, Stenb\u00e4ck V, Gagnon DD et al (2020) (Neuro) Peptides, Physical Activity, and Cognition. J Clin Med 9(8):2592. https:\/\/doi.org\/10.3390\/jcm9082592","journal-title":"J Clin Med"},{"key":"5803_CR215","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2018.00493","author":"X-Y Chen","year":"2019","unstructured":"Chen X-Y, Du Y-F, Chen L (2019) Neuropeptides exert neuroprotective effects in Alzheimer\u2019s disease. Front Mol Neurosci. https:\/\/doi.org\/10.3389\/fnmol.2018.00493","journal-title":"Front Mol Neurosci"},{"issue":"11","key":"5803_CR216","doi-asserted-by":"publisher","first-page":"2353","DOI":"10.1007\/s00213-025-06840-9","volume":"242","author":"M-J Yang","year":"2025","unstructured":"Yang M-J, Jia M, Cai M et al (2025) Central neuropeptides as key modulators of astrocyte function in neurodegenerative and neuropsychiatric disorders. Psychopharmacology 242(11):2353\u20132371. https:\/\/doi.org\/10.1007\/s00213-025-06840-9","journal-title":"Psychopharmacology"},{"key":"5803_CR217","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.semcancer.2022.12.009","volume":"88","author":"X He","year":"2023","unstructured":"He X, Liu X, Zuo F et al (2023) Artificial intelligence-based multi-omics analysis fuels cancer precision medicine. Semin Cancer Biol 88:187\u2013200. https:\/\/doi.org\/10.1016\/j.semcancer.2022.12.009","journal-title":"Semin Cancer Biol"},{"key":"5803_CR218","doi-asserted-by":"publisher","DOI":"10.1016\/j.apsb.2025.07.030","author":"F Ren","year":"2025","unstructured":"Ren F, Wei J, Chen Q et al (2025) Artificial intelligence-driven multi-omics approaches in Alzheimer\u2019s disease: Progress, challenges, and future directions. Acta Pharmaceutica Sinica B. https:\/\/doi.org\/10.1016\/j.apsb.2025.07.030","journal-title":"Acta Pharmaceutica Sinica B"},{"issue":"12","key":"5803_CR219","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1152\/physiolgenomics.00011.2024","volume":"56","author":"R Tambi","year":"2024","unstructured":"Tambi R, Zehra B, Vijayakumar A et al (2024) Artificial intelligence and omics in malignant gliomas. Physiol Genomics 56(12):876\u2013895. https:\/\/doi.org\/10.1152\/physiolgenomics.00011.2024","journal-title":"Physiol Genomics"},{"issue":"6","key":"5803_CR220","doi-asserted-by":"publisher","first-page":"5070","DOI":"10.55248\/gengpi.6.0125.0650","volume":"6","author":"OS Bakare","year":"2025","unstructured":"Bakare OS (2025) AI-driven multi-omics integration for precision medicine in complex disease diagnosis and treatment. International Journal of Research Publication and Reviews 6(6):5070\u20135084. https:\/\/doi.org\/10.55248\/gengpi.6.0125.0650","journal-title":"International Journal of Research Publication and Reviews"},{"key":"5803_CR221","doi-asserted-by":"publisher","DOI":"10.1007\/s10142-024-01417-9","author":"F Ozcelik","year":"2024","unstructured":"Ozcelik F, Dundar MS, Yildirim AB et al (2024) The impact and future of artificial intelligence in medical genetics and molecular medicine: an ongoing revolution. Funct Integr Genomics. https:\/\/doi.org\/10.1007\/s10142-024-01417-9","journal-title":"Funct Integr Genomics"},{"key":"5803_CR222","doi-asserted-by":"publisher","DOI":"10.1016\/j.sbi.2024.102776","volume":"85","author":"Y Qiu","year":"2024","unstructured":"Qiu Y, Cheng F (2024) Artificial intelligence for drug discovery and development in Alzheimer\u2019s disease. Curr Opin Struct Biol 85:102776. https:\/\/doi.org\/10.1016\/j.sbi.2024.102776","journal-title":"Curr Opin Struct Biol"},{"issue":"5","key":"5803_CR223","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1038\/s12276-024-01218-x","volume":"56","author":"JH Yoon","year":"2024","unstructured":"Yoon JH, Lee D, Lee C et al (2024) Paradigm shift required for translational research on the brain. Exp Mol Med 56(5):1043\u20131054. https:\/\/doi.org\/10.1038\/s12276-024-01218-x","journal-title":"Exp Mol Med"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-026-05803-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-026-05803-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-026-05803-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T06:19:04Z","timestamp":1773901144000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-026-05803-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":223,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["5803"],"URL":"https:\/\/doi.org\/10.1007\/s12035-026-05803-1","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"29 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"508"}}